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INTRODUCTION 
 
Historically, selection within the Holstein breed in the US has emphasized 
increased production alongside conformation traits such as shallower udders, increased 
body size, and greater dairy form (Rauw et al., 1998; Hansen, 2000; Haile-Mariam and 
Goddard, 2010).  These traits are highly heritable and dairy producers have chosen to 
optimize production of their cows with the intent of maximizing profit.  However, this 
selection success has been accompanied by a decline in cow health and welfare (Oltenacu 
and Broom, 2010; Becker et al., 2012), which can negatively impact the profitability of 
cows.  As a result, selection for improved health is of increasing importance to dairy 
producers.  However, health disorders are difficult to evaluate in the US because uniform 
recording systems for health data are not utilized, inhibiting the genetic evaluation of 
health traits (Zwald et al., 2004a; Parker Gaddis et al., 2014). 
Health Data 
A 2007 USDA study reported 93% of US dairy operations with 500 cows or more 
use some form of a computerized record keeping system for health data.  Among these 
herds, 3 primary software programs are used.  The programs are Dairy Comp 305 (Valley 
Agricultural Software, Tulare, CA), which is used by 35% of herds, followed by 
PCDART (Dairy Records Management Systems, Raleigh, NC) with 19%, and 15% of 
herds use DHI Plus (DHI Computing Services Inc., Provo, UT) (USDA, 2007; Wenz and 
Giebel, 2012).  
Many large farms record health data, but health disorders are difficult to analyze 
because health data lacks consistency and is often incomplete (Parker Gaddis et al., 
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2014).  For example, some software programs offer tremendous flexibility such that the 
same health disorder may be entered into the system in different ways.  Entries into Dairy 
Comp 305 tend to be recorded in character acronyms up to 4 letters, whereas PCDART 
follows a character acronym format of up to 7 letters (Zwald et al., 2004a), and Wenz and 
Giebel (2012) reported 3 to 4 different acronyms were sometimes used within a single 
farm to record metritis.  Zwald et al. (2004a) used data from cooperator herds of the 
Advantage Progeny Test Program from Alta Genetics (Watertown, WI) to assess the 
health of dairy cows.  They found the 724 herds that recorded mastitis did so using 20 
various abbreviations via PCDART.  
High-quality health data can contribute to the improvement of management 
decisions and reduce mortality of cows among herds (Dechow and Goodling, 2008).  
Cows with a health disorder early in lactation are at an increased risk of a health disorder 
later in lactation (Parker Gaddis et al., 2012) and knowledge of previous health disorders 
allows dairy producers to identify cows that may require attention later in lactation.  
Furthermore, complete and uniform health data can be valuable for minimizing health 
treatment costs through better identification of health disorders for individual cows as 
well as for improved culling decisions to remove cows with extensive health disorders 
from the herd. 
The lack of uniformity of recording for health data makes it difficult to 
summarize health disorders within and between dairy herds.  Also, when recording health 
data, dairy producers may not consistently distinguish the difference between incidence 
and treatment of health disorders.  Parker Gaddis et al. (2012) reported that incidence 
 3 
 
 
 
rates of health disorders in their study were lower than other literature estimates, which 
could suggest dairy producers are more likely to record only health treatments rather than 
to record every health diagnosis.  Further review of the literature (Lyons et al., 1991; 
Kelton et al., 1998; Zwald et al., 2004a,b; Koeck et al., 2012; Parker Gaddis et al., 2012) 
suggests a need for a more comprehensive and uniform approach to recording of health 
data to enable the data to be used more effectively for day-to-day management decisions 
and for research.  
Several European countries have required recording of all health treatments of 
dairy cows for over 30 years with health treatments systematically recorded by 
veterinarians on an individual animal basis (Ruane et al., 1997; Parker Gaddis et al., 
2014), which permits the evaluation of health disorders within and between herds.  
Furthermore, Scandinavian countries have successfully included health data in their total 
merit index (TMI) (Philipsson and Lindhé, 2003; Abdel-Azim et al., 2005), and this 
permitted effective selection for fewer health disorders.  Outside of Europe, several 
studies (Lyons et al., 1991; Zwald et al., 2004a,b; Koeck et al., 2012; Neuenschwander et 
al., 2012) found that utilization of health data for genetic evaluation of common health 
disorders is possible; however, improving the integrity and uniformity of health data is 
necessary for genetic evaluation.  
Incidence Rates of Health Disorders 
 Several studies of health data recorded on-farm for incidence rates of common 
health disorders of dairy cows required extensive scrutiny and editing prior to analysis to 
ensure reliable and consistent reporting across dairy herds (Koeck et al., 2012).  Each of 
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the studies reviewed hereafter have calculated incidence rates of health disorders based 
on lactations of cows that had at least one incidence of a specific health disorder.  
Appuhamy et al. (2009) reported mastitis, reproduction disorders (metritis, retained 
placenta, and cystic ovaries), metabolic disorders (ketosis and displaced abomasum), and 
lameness incidence rates using health data from 398 commercial dairy herds processed by 
Dairy Records Management Systems (Raleigh, NC), and found first-parity incidence 
rates of 9.5%, 17.7%, 6.4%, and 13.3% for mastitis, reproduction disorders, metabolic 
disorders, and lameness, respectively.  In later parities, greater incidence rates of 12.7%, 
20.3%, 7.0%, and 17.7% for mastitis, reproduction disorders, metabolic disorders, and 
lameness were reported (Appuhamy et al, 2009). 
 First-parity health data of Canadian Holsteins provided by the Canadian Dairy 
Network from 2007 to 2011 were analyzed by Koeck et al. (2012).  Incidence rates were 
reported for mastitis (12.6%), displaced abomasum (3.7%), ketosis (4.5%), retained 
placenta (4.6%), metritis (10.8%), cystic ovaries (8.2%), lameness (9.2%), and milk fever 
(0.20%).  In another study, Zwald et al. (2004a) used health data from US dairy herds and 
reported similar incidence rates for displaced abomasum (3%), cystic ovaries (8%), and 
lameness (10%) to those reported by Koeck et al. (2012), but greater incidence rates for 
mastitis (20%), ketosis (10%), and metritis (21%) than the Canadian study (Koeck et al. 
2012).  Parker Gaddis et al. (2012), also analyzed health records from US dairy herds, but 
found lower incidence rates than Zwald et al. (2004a) for displaced abomasum (2.2%), 
cystic ovaries (3.5%), lameness (6.4%), mastitis (12.3%), ketosis (5.2%), and metritis 
(6.9%).  
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 Appuhamy et al. (2007) analyzed treatment records of 991 Holstein lactations 
from 2 institutional herds.  In that study, ketosis and milk fever were combined for 
evaluation of metabolic disorders.  Across all parities, mastitis had the highest incidence 
rate of 30.5%, followed by lameness (26%), and then metabolic disorders (12.4%).  
Becker et al. (2012) analyzed treatment records of Holstein cows at the Northwest 
Research and Outreach Center (Crookston, MN) of the University of Minnesota from 
1983 to 2005.  Cows were grouped based on selection for large versus small body size 
and the incidence rates for health treatments of the large cows was 24.6%, 41.2%, and 
23.6% for mastitis, locomotion, and reproduction, respectively.  A possible reason for the 
greater incidence rates reported in studies using institutional herds versus commercial 
herds is because the health data is more likely to be thoroughly recorded in institutional 
herds, and institutional herds typically receive frequent support from veterinarians.  
Furthermore, institutional herds may not be as profit-driven as commercial herds and may 
be more likely to invest in treatment of a health disorder for a cow, rather than culling a 
cow for a health disorder.  
Incidence rates of health disorders are difficult to compare across research studies 
because differences exist among recording strategies, health disorder definitions, and 
diagnosis of health disorders (Harder et al., 2006).  Parker Gaddis et al. (2012) 
summarized incidence rates across 30 research studies, and mastitis, lameness, and 
metritis occurred most frequently.  Mastitis incidence ranged from 1% to 39%, with a 
mean of 18%. Metritis incidence ranged from 1.8% to 35.5%, with a mean of 12.3%, and 
lameness incidence ranged 2.5% to 30.4%, with a mean of 9.3%.  The large range of 
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incidence rates for health disorders suggests the need for a more systematic and uniform 
approach of health recording.  
Health Disorders by Stage of Lactation 
Across the literature (Appuhamy et al., 2009; Harder et al., 2006; Parker Gaddis 
et al., 2012), a majority of health disorders of cows occurred within the first 30 to 60 days 
in milk (DIM).  Most of the disorders were related to reproduction and metabolism, likely 
because cows experienced negative energy balance as a consequence of the demand for 
nutrients to produce milk (Sundrum, 2015).  Transition disorders such as displaced 
abomasum, ketosis, and metritis occurred most commonly during the first 30 DIM 
(Zwald et al., 2004a; Koeck et al., 2012) and greater than 90% of ketosis cases occurred 
in the first 30 DIM.  For cases of displaced abomasum, Zwald et al. (2004a) reported that 
78.5% occurred within the first 30 DIM, but Koeck et al. (2012) reported a higher 30-
DIM occurrence rate of 91%.  Also, mastitis commonly occurs during the first 30 DIM, 
and Zwald et al. (2004a) and Koeck et al. (2012) found incidence rates of 23.4% and 
35%, respectively during the first 30 DIM.   
Koeck et al. (2012) found that lameness disorders were, in general, evenly 
distributed across lactation, but they were slightly greater during the first 90 DIM; 
however, this differed from Zwald et al. (2004a), who found slightly greater incidence of 
lameness in early- (0 to 30 DIM), mid- (151 to 180 DIM) and late- (> 360 DIM) 
lactation.  Both Koeck et al. (2012) and Zwald et al. (2004a) reported incidence of cystic 
ovaries was highest from 31 to 150 DIM, from the disorder being discovered during 
palpation at breeding time.  
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Cost of Health Disorders 
  Health disorders impact farm profitability by increasing costs due to veterinary 
services and pharmaceuticals and decreased milk production (Wells et al., 1998).  
Additionally, cows with mastitis, lameness, or metabolic disorders early in lactation 
subsequently often have impaired fertility and may acquire additional cost from delayed 
conception (Weigel, 2004; Guard, 2008).  Some treatments for health disorders have 
tremendous cost; however, dairy producers may have difficulty assigning a cost to 
specific health disorders, because records may not always encompass the time, the type, 
and the dosages of pharmaceuticals used for individual health treatments.  
 Mastitis, reproduction, lameness, and metabolic disorders are among the most 
expensive health disorders (Wells et al., 1998; Zwald et al., 2004a).  Bar et al. (2008) 
estimated the cost of clinical mastitis in 5 New York dairy herds and found the mean cost 
of a single case to be $179, which includes lost milk production ($115), treatment cost 
($50), and cost associated with increased mortality ($14).  When evaluating the treatment 
of clinical mastitis without accounting for lost production, Ettema and Santos (2004) 
reported a treatment cost of $50.80.  Guard (2008) reported a slightly lower treatment 
cost of $27 per case of clinical mastitis; however, the total cost was $224 per clinical case 
when the costs of veterinary attention, labor, decreased milk production, delayed 
conception, death, and culling were included.  Differences in approach to treatment, 
utilization of discarded milk, and culling policies are possible reasons for differences in 
treatment cost assigned to mastitis across the studies. 
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 Beside mastitis, Guard (2008) estimated the cost for treatment (veterinary 
services, pharmaceuticals, and labor fees) of other major health disorders, such as milk 
fever ($24), retained placenta ($27), ketosis ($25), displaced abomasum ($131), and 
lameness ($31).  Displaced abomasum often has a high treatment cost because it 
frequently requires surgery.  Ettema and Santos (2004) reported a range of $40 to $170 
for the treatment of displaced abomasum depending on the treatment method.  For health 
disorders in first parity, Zwald et al. (2004b) estimated the total health cost for cows 
ranged from $128 to $169.  Treatment costs for health disorders vary depending on the 
expense of pharmaceuticals used for treatment and because some pharmaceuticals do not 
require milk to be discarded (Guard, 2008).   
Heritability of Health Traits 
  Heritability estimates for health traits from the literature are generally low to 
moderate.  Differences among the estimates are due to differing statistical approaches for 
analysis as well as the quality of data, the definition of reported health disorders, and 
sample size (Lin et al., 1989).  Heritability estimates from 10 research studies from 1989 
to 2012 for mastitis, retained placenta, metritis, cystic ovaries, displaced abomasum, 
ketosis, and lameness are reviewed in Table 1.  The majority of these studies estimated 
the heritability of health disorders based on incidence from binary recording (0 = absence 
of health disorder, 1 = presence of health disorder).  The most recent study (Appuhamy et 
al., 2009) using health data of US dairy cows found the heritability of individual health 
disorders ranged from 0.01 (ketosis) to 0.10 (metritis).  
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Across all studies reviewed in Table 1, mastitis tended to have the highest 
heritability estimates.  Mastitis is the health disorder most consistently recorded in 
commercial dairy herds along with displaced abomasum (Zwald et al., 2004a,b), probably 
because both disorders can have large economic impact.  Besides this, displaced 
abomasum usually requires attention from a veterinarian.  Estimates of heritability for 
lameness were usually low, and Zwald et al. (2004b) hypothesized that the low 
heritability (0.06) may have resulted from of inconsistent recording of lameness 
compared to other health disorders.  A possible explanation for the inconsistent recording 
of lameness is some dairy producers may have chosen to cull a cow for lameness rather 
than provide treatment.  
 Lyons et al. (1991) combined incidence of abortion, cystic ovaries, retained 
placenta, uterus infection, number of inseminations, and other reproduction disorders into 
a reproduction category and found a heritability of 0.02.  Dechow et al. (2004) grouped 
incidence of cystic ovaries, retained placenta, and uterine infection together in a 
reproduction category, and this also resulted in a heritability of 0.02.  Some studies 
grouped all metabolic and digestive disorders for analysis, and heritability estimates of 
0.05 (Gernand et al., 2012) and 0.17 (Lyons et al., 1991) were reported.  Inconsistencies 
among estimates may be due to variability in which health disorders were included in the 
categories. 
 Zwald et al. (2004a) pooled all health disorders from the first 50 DIM and 
reported a heritability of 0.12 for first parity and 0.10 across parities.  Similarly, Gernand 
et al. (2012) analyzed the incidence of at least 1 health disorder of cows throughout a 
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single lactation, and found a lower heritability of 0.04 across parities.  Lyons et al. (1991) 
estimated the heritability (0.07) of the sum of all health incidences in a single lactation.  
Overall, heritability estimates for health disorders from each of these studies indicates 
genetic selection should be possible for at least some health disorders.  Because of the 
monetary and animal welfare impacts associated with health disorders of dairy cows, 
more research using high-quality health data should be conducted in an effort to include 
health traits in genetic evaluations for US dairy cattle.  
Genetic and Phenotypic Correlations between Health Disorders 
Lyons et al. (1991) reported a genetic correlation between mammary disorders 
(mastitis, udder injury, and other udder problems) and digestive disorders of 0.52 and a 
genetic correlation between mammary and locomotion disorders of 0.82.  However, they 
reported a low and negative genetic correlation (-0.11) between mammary disorders and 
reproduction disorders.  Zwald et al. (2004b) found genetic correlations among health 
disorders ranged from -0.01 between mastitis and metritis to 0.45 between displaced 
abomasum and ketosis.  Furthermore, Zwald et al. (2004b) found moderate genetic 
correlations between cystic ovaries and ketosis (0.42) and lameness and mastitis (0.20).  
Koeck et al. (2012) estimated higher genetic correlations than Zwald et al. (2004b), 
especially between displaced abomasum and retained placenta (0.64) and between 
retained placenta and metritis (0.62).  The larger genetic correlations of Koeck et al. 
(2012) may be due to the higher quality of their data from Canadian herds in their 
analysis, as well as a greater effort by the dairy producers to record health incidences as 
the study progressed.  
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The genetic correlations between individual health disorders reported by Zwald et 
al. (2004b) and Koeck et al. (2012) tend to agree with those of Heringstad et al. (2007), 
who hypothesized genetic selection against certain health disorders such as mastitis may 
lead to increased resistance of other health disorders including ketosis and retained 
placenta for Norwegian Red cows.  Zwald et al. (2004b) also concluded the positive 
genetic correlations between many health disorders may indicate that daughters of certain 
bulls may be more predisposed to all health disorders compared to daughters of other 
bulls.  Overall, the strong genetic correlations between health disorders often found in 
these studies suggests a selection index including all health disorders could be effective 
for the genetic improvement of health of dairy cows.  
Phenotypic correlations between health disorders reported by Koeck et al. (2012) 
ranged from 0.00 (ketosis with cystic ovaries) to 0.27 (ketosis with displaced abomasum).  
The phenotypic correlation between retained placenta and metritis was 0.14, and all other 
reported phenotypic correlations were low.  The phenotypic correlation of 0.27 between 
ketosis and displaced abomasum was not surprising because both of these disorders are 
often a result of negative energy balance after calving, and ketosis has been reported as a 
risk factor for displaced abomasum (LeBlanc, 2005).  Lyons et al. (1991) analyzed 
reproduction, mammary, digestive, locomotion, and respiratory disorders, and they found 
the highest phenotypic correlation was between locomotion and digestive disorders 
(0.12).  Perhaps that phenotypic correlation is a result of nutritional factors causing 
digestive disorders, such as acidosis, which can lead to hoof health disorders (Stone, 
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2004).  Other phenotypic correlations among the aforementioned health disorders were 
small and ranged from -0.03 to 0.09 for Lyons et al. (1991).  
Health Disorders and their Genetic Relationships with Production and Conformation 
 Rupp and Boichard (1999) reported a genetic correlation of 0.45 between milk 
production and mastitis, and this was greater than the more modest estimates of 0.15 and 
0.18 found by Van Dorp et al. (1998) and Lyons et al. (1991), respectively.  Pryce et al. 
(1997) reported genetic correlations of 0.21 between milk production and mastitis and 
0.29 between milk production and hoof health disorders.  Van Dorp et al. (1998) also 
reported genetic correlations between milk production and cystic ovaries (0.23) and 
between milk production and lameness (0.24).  Lyons et al. (1991) estimated genetic 
correlations between milk production and the health categories of reproduction (-0.27), 
mammary (0.18), digestive (0.44), locomotion (0.48), and respiratory (0.02) disorders, 
respectively.  Furthermore, Jones et al. (1994) analyzed the difference in health cost of 
Holstein cows selected for milk production versus a 1964 control line of Holsteins and 
found cows selected for milk production had greater health cost ($64.71) than the control 
line ($39.19) for first parity.   
The genetic relationships between milk production and some health disorders in 
the previously mentioned studies document the antagonistic relationship between higher 
milk production and many health disorders; however, the magnitude of the genetic 
correlations varied greatly due to statistical approach, sample size, quality of data, or 
several of these factors combined.  Nonetheless, the antagonistic genetic relationships 
should be taken into account for genetic improvement of dairy cattle.  While increased 
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milk production may lead to more income from milk sales, the costs associated with 
health disorders resulting from the higher milk production should also be considered.  
Furthermore, Oltenacu and Broom (2010) suggested the impaired health of cows is 
indicative of a decline in cow welfare, and animal welfare is perceived by the public as 
an indicator of product quality and, thus, an additional contributor to economic value.  
The genetic correlations among conformation and health disorders have been 
studied less frequently, likely because conformation scores are usually not uniformly 
recorded for large populations of cows across parities.  Rupp and Boichard (1998) 
reported a moderate negative genetic correlation (-0.46) between mastitis and udder 
depth, which indicated daughters of bulls with more shallow udders had less mastitis.  
This makes sense because deeper udders would have more functional problems with 
milking (Hansen et al., 1999), which in turn could result in mastitis.  In contrast, Van 
Dorp et al (1998) found no genetic correlation (0.00) between udder depth and mastitis.  
The favorable genetic correlation between udder depth and mastitis of Rupp and 
Boichard (1998) suggests selection for higher udders should reduce incidence of mastitis, 
which is important from both a cow health and economic perspective.   
Dechow et al. (2004) reported a strong genetic correlation between dairy form and 
the incidence of any health disorder (0.85), and this suggested daughters of bulls that 
transmitted greater dairy form were at an increased risk for health disorders.  In that 
study, the magnitude of the genetic correlation between dairy form and health was mostly 
due to metabolic and digestive disorders, which had a genetic correlation of 0.65 with 
dairy form.  Greater dairy form is associated with lower body condition; therefore, a 
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possible reason for the unfavorable genetic correlation between dairy form and health 
may be due to cows with low body condition are more likely to experience severe 
negative energy balance following calving (Dechow et al., 2004).  The unfavorable 
genetic correlation between dairy form and cow health suggests selection for more 
moderate dairy form may lead to fewer health disorders.  
Becker et al. (2012) compared health cost of Holsteins selected for small versus 
large body size, and cows selected for large body size had $21 more health costs for first 
parity than cows selected for small body size.  Also, Hansen et al. (1999) reported that 
Holstein cows selected for large body size had shorter productive life than Holstein cows 
selected for small body size.  Moreover, Zwald et al. (2004b) found that body size traits 
of Holsteins had a negative relationship to disease resistance.  The antagonistic 
relationship between body size and health of dairy cows should be considered in the 
selection plans of individual dairy herds.  Larger cows typically have an advantage in the 
show ring, but larger cows may have more health costs.  
Justification and Objectives of Research 
 Health data from commercial dairy herds is often inconsistently recorded and 
lacks completeness; therefore, the determination of cost for health disorders and the 
inclusion of health traits in US genetic evaluations are inhibited.  The primary objectives 
of this study were to assess the health treatment costs of Holstein cows and estimate their 
genetic parameters from data uniformly recorded in 8 high-performance Minnesota dairy 
herds.   
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Table 1. Heritability estimates of common health disorders among dairy cows  
Author Year Mastitis 
Retained 
placenta Metritis Cystic ovaries 
Displaced 
abomasum Ketosis Lameness 
Lin et al. 1989 0.19 0.05 0.19 0.12 --- --- --- 
Lyons et al. 1991 0.14 0.05 0.061 0.05 0.09 0.08 --- 
Uribe et al. 1995 0.15 --- --- 0.17 0.30 0.10 --- 
Van Dorp et al. 1998 0.04 0.01 0.02 0.02 0.00 0.39 0.16 
Dechow et al.2 2004 0.02 - 0.06 --- --- 0.02 - 0.17 0.08 --- --- 
Zwald et al. 2004 0.09 --- 0.07 0.05 0.15 0.06 0.06 
Abdel-Azim et al.  2005 --- --- 0.141 0.03 0.09 --- --- 
Appuhamy et al.2 2009 0.10 --- 0.04 - 0.10 --- 0.03 0.01 --- 
Neuenschwander et al.2  2012 0.01 - 0.05 0.07 0.02 - 0.03 0.05 0.21  0.09 0.04 - 0.05 
Koeck et al.  2012 0.02 0.03 0.02 0.03 0.06 0.03 0.01 
Gernand et al. 2012 0.06 0.04 --- 0.06 --- --- --- 
1Estimates are based on general uterine infection. 
2Range of estimates reflect different statistical approaches within study.  
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Health treatment cost of Holsteins in 8 high-performance herds. 
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INTERPRETIVE SUMMARY 
Health treatments of Holsteins were recorded over an 8-year period of time and 
partitioned into 5 categories (mastitis, reproduction, lameness, metabolic, and 
miscellaneous).  Fixed costs of health treatments were obtained from the veterinary 
clinics that serviced the 8 herds, and they were assigned to each observation.  Health 
treatment cost of cows was highest during the first 30 days in milk for all parities and 
means ranged from $22.87 in first parity to $38.50 in fifth parity.  The total of health 
treatment cost during first parity had means that ranged from $23.38 to $74.60 for the 8 
herds and usually increased with parity. 
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MANUSCRIPT 1 ABSTRACT 
Health treatments of Holstein cows (n = 2,214) were recorded by the owners of 8 
high-performance dairy herds in Minnesota.  Cows calved from March 2008 to October 
2015, and 14 types of health treatments were uniformly defined across the herds.  
Specific types of health treatment were subsequently assigned a cost based on the mean 
veterinary cost obtained from the veterinary clinics that serviced the 8 herds.  A fixed 
labor cost for time ($18/h) associated with specific types of health treatment was 
determined based on interviews with the herd owners and was added to the veterinary 
cost.  Health treatment cost was partitioned into 5 health categories: mastitis (including 
mastitis diagnostic test), reproduction (cystic ovary, retained placenta, and metritis), 
lameness (hoof treatments), metabolic (milk fever, displaced abomasum, ketosis, and 
digestive), and miscellaneous (respiratory, injury, and other).  Lactations of cows were 
divided into 6 intervals that corresponded with stage of lactation based on days in milk.  
The first interval of lactation was 30 days in length, followed by 4 intervals of 60 days 
each, and the final interval started on day 271 and had variable length because it 
continued to the end of lactation and included the dry period.  Health treatment cost was 
summed within each interval of lactation and subsequently across lactations by parity.  
Statistical analysis by parity included the fixed effects of herd, interval, and the 
interaction of herd and interval, with interval regarded as a repeated measure of cows.  
Means for health treatment cost were highest during the first interval for all 5 parities of 
cows and ranged from $22.87 for first parity to $38.50 for fifth parity.  Reproduction 
treatment cost was about one-half of total health treatment cost during the first interval 
for all 5 parities.  Metabolic treatment cost for the first interval ranged from $3.92 (in first 
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parity) to $12.34 (in third parity).  Compared to other health categories, mastitis treatment 
cost was evenly distributed across intervals of lactation for all parities.  Lameness 
treatment cost was highest during mid- or late-lactation across parities and reflected the 
time when cows received routine hoof trimming.  Additionally, treatment cost across 
health categories was summed over intervals of lactation for each cow, and the total 
health cost of cows varied substantially from herd to herd and means ranged from $23.38 
to $74.60 for first parity and usually increased with parity. 
 
Keywords: Health treatment cost, Holstein, transition disorder 
 
INTRODUCTION 
 Traditionally, selection within the Holstein breed in the US placed major 
emphasis on production and conformation traits (Hansen, 2000).  This approach was 
accompanied by a decline in cow health and welfare (Oltenacu and Broom, 2010), which 
negatively impacts the profitability of cows.  The impact of health disorders on 
profitability of cows is difficult to measure, because most health data recorded on farms 
lack uniformity and are often incomplete.  Furthermore, most herd owners do not record 
the cost of individual health treatments of cows.  Determining the full economic impact 
of heath disorders is complicated because health disorders impact involuntary culling, 
fertility, and production which, in turn, influence profitability (Zwald et al., 2004; Guard, 
2008). 
The majority of metabolic and infectious health disorders occur within the first 30 
to 60 days of lactation (Harder et al., 2006; Appuhamy et al., 2007; Parker Gaddis et al., 
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2012) and may be caused by a depressed immune system and the negative energy balance 
created by the demand for nutrients to produce milk (Esposito et al., 2014).  In a 
summary of previous studies, Parker Gaddis et al. (2012) reported lactational incidence 
rates were highest for mastitis, lameness, and metritis, and incidence of mastitis ranged 
from 1.0% to 39.1% with a mean of 18.0%, metritis ranged from 1.8% to 35.5% with a 
mean of 12.3%, and lameness ranged from 2.5% to 30.4% with a mean of 9.3%.  
Differences in recording methods, definition of health disorders, and diagnosis protocols 
have created variability of results from study to study; therefore, incidence rates of health 
treatments are difficult to compare across studies (Harder et al., 2006). 
Clinical mastitis often results in reduced production (Shim et al., 2004) and 
metabolic disorders, lameness, and mastitis tend to negatively impact fertility (Weigel, 
2004).  Ettema and Santos (2004) estimated the cost per case of mastitis was $51, and this 
included the cost of antibiotic treatment, labor, and 5 d of discarded milk.  Guard (2008) 
estimated a much higher cost of $224 per case of mastitis when lost revenue from 
reduced milk production, delayed conception, death, and involuntary culling was 
included.  Jones et al. (1994) analyzed the health treatment costs of an experimental herd 
of Holsteins selected for milk production versus a 1964 control line, and the cows 
selected for milk production had $28.22 more health treatment cost during first parity 
than the control line.  In that study, 43% ($27.79) of the cost during first parity was 
attributed to mastitis (Jones et al., 1994).  
Reducing the incidence of health disorders of dairy cows is of growing interest to 
herd owners.  To be sure, SCS (as an indicator of mastitis) and productive life (a 
composite trait including production and functional traits of cows) are two traits that have 
 29 
 
permitted selection for improved health of cows in the US (García-Ruiz et al., 2016).  
Improving the integrity and uniformity of health data recorded on farms will provide an 
opportunity to assess the economic impact of health disorders and allow for selection of 
reduced health treatment cost (Parker Gaddis et al., 2012, 2014).  The objective of this 
study was to analyze the health treatment cost of Holstein cows from parity 1 to 5 using 
on-farm data for treatments that were defined uniformly within 8 high-performance 
Minnesota dairy herds. 
MATERIALS AND METHODS 
Description of Herds and Cows 
Holstein cows in 8 dairy herds throughout Minnesota with very high mean 
production were enrolled by the University of Minnesota from March to September of 
2008 to initiate a long-term study.  All herds housed cows in 4- or 6-row freestall 
facilities and fed cows a TMR.  In June 2016, the herds ranged in size from 302 to 1,932 
cows with a mean herd size of 981 cows, and the weighted mean production for all cows 
in the 8 herds was 14,019 kg of milk, 519 kg of fat, and 433 kg of protein.  
 Each of the 8 herds offered varying numbers of cows and nulliparous heifers for 
the study.  In total 3,550 Holstein females were enrolled, ranging from 266 to 785 
females in each herd.  Matings were completed by 2 genetic advisors employed by 
Minnesota Select Sires Co-op, Inc., St. Cloud, MN.  Herd owners chose proven AI bulls 
and were asked to select bulls that ranked among the top 10% for the Net Merit index for 
Holstein bulls (VanRaden and Cole, 2014).  Following the selection of AI bulls, lactating 
cows were correctively mated for conformation, and all virgin heifers were correctively 
mated based on their dams’ conformation when possible.  Also, some virgin heifers and 
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cows were mated to proven AI bulls from the Montbeliarde and Viking Red breeds.  All 
matings of Holstein bulls to Holstein females were provided inbreeding protection. 
Data 
Lactational Records.  Data were lactational health records from Holstein females 
for parity 1 to 5 for lactations that were initiated from March 2008 to October 2015.  
Cows with a single lactation that was initiated by an abortion were eliminated from the 
data.  In total, 5,052 cows with 11,862 lactations were available for analysis, and the 
number of cows and lactations following successive steps of editing are reviewed in 
Table 1.  The lactations beginning with an abortion (for cows with multiple lactations) 
were removed, and lactations of all cows were required to have the opportunity to reach 
at least 30 DIM.  Furthermore, only lactations of cows that had a first parity commencing 
after March 2008 were studied.  All cows and their dams were required to be sired by an 
AI bull with a sire code from the National Association of Animal Breeders (Columbia, 
MO).  Additional edits eliminated cows with sires that had only a single daughter and 
with maternal grandsires that had only a single daughter or granddaughter.  The edits that 
were based on the pedigree of cows were applied to improve the accuracy of sire and 
maternal grandsire identification.  Following all edits, 2,214 cows with 4,979 lactations 
of variable length for parity 1 to 5 remained for analysis.  The distribution of lactations of 
cows by herd and parity is in Table 2, and data for parity 4 (7%) and parity 5 (3%) were 
sparse.   
Data for Health Treatment and Cost. Health treatments were uniformly defined 
for 14 individual health disorders across the 8 herds and recorded on-farm with Dairy 
Comp 305 (Valley Ag Software, Tulare, CA).  Monthly backups from Dairy Comp 305 
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were obtained from the 8 herds, and data were verified for accuracy.  The monthly 
collection and verification of the data prevented the deletion of data by the software and 
improved the integrity of the data.  The health treatments were partitioned into 5 
categories: mastitis (MAST), reproduction (REPRO), lameness (LAME), metabolic 
(META), and miscellaneous (MISC).  The specific health treatments that were assigned 
to each of the 5 categories are reviewed in Table 3.  
Incidence rates of health treatments are commonly reviewed in the literature; 
however, no previous study has investigated the cost of health treatments from field data 
in the US.  Therefore, this study is unique because it analyzes the cost rather than the 
incidence of health treatments from field data.  A total cost for each specific type of 
health treatment (Table 4) was determined by summing the respective veterinary cost and 
the labor cost that was associated with each treatment.  Veterinary cost was the mean cost 
for specific types of health treatment protocols that were obtained from the veterinary 
clinics that serviced each herd, and this included veterinary labor (when applicable), 
veterinary supplies, and pharmaceuticals.  Farm labor cost was assigned a fixed value of 
$18/h, and the time assigned to each specific type of treatment was based on an interview 
with the 8 herd owners.  The time assigned to each treatment reflected the time required 
for animal attendants to restrain the cow and administer the health treatment.  For cows 
with more than 1 treatment of the same type, a new health treatment was triggered for 
cows when 3 d passed between hoof treatments, when 5 d passed between digestive, 
ketosis, mastitis, metritis, milk fever, and respiratory treatments, and when 7 d passed 
between cystic ovary treatments.  Only a single treatment for displaced abomasum, 
retained placenta, and miscellaneous reproduction was permitted per lactation.  No 
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restriction on days between treatments was applied to mastitis diagnostic test, injury, or 
other treatments.  
Intervals of Lactation.  The time within lactation when health treatment cost 
occurred was of special interest in this study; therefore, lactations of cows were divided 
into 6 intervals that corresponded to stage of lactation and were based on DIM.  The first 
interval began at calving and was 30 d in length.  The subsequent 4 intervals were each 
60 d in length (31 d to 90 d, 91 d to 150 d, 151 d to 210 d, and 211 d to 270 d), and the 
final interval started at 271 DIM and had variable length because it continued to the end 
of lactation and included the dry period.  Health treatment cost within each health 
category was summed to obtain an interval cost by health category.  Additionally, the 
health treatment cost across the 5 categories for a lactation of a cow was, in turn, summed 
within interval to arrive at the total health treatment cost (TOT) for that interval.  Finally, 
the TOT for the 6 intervals of lactation were summed to obtain the total lactational health 
cost (THC) of each lactation of a cow.  The THC for cows with incomplete lactations 
was simply the THC from calving to the end of the study (November 2015) without any 
sort of adjustment.  
Statistical Analysis of Health Treatment Cost 
Analysis was conducted separately by parity.  For analysis of health treatment 
cost by interval within lactation, dependent variables were the cost of each of health 
category as well as TOT.  Independent variables were the fixed effects of herd, interval, 
and the interaction of herd and interval, with interval regarded as a repeated measure for 
cows.  An attempt was made during preliminary analysis to fit the fixed effects of year 
and season of calving; however, they did not significantly account for variation.  A 
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separate analysis assessed the THC of cows (dependent variable), and the independent 
variables were herd as a fixed effect and cow as a random variable.  The MIXED 
procedure of SAS 9.3 (SAS Institute, 2011) was used to conduct the ANOVA and to 
obtain least squares solutions.  Both of the analyses were, again, conducted separately by 
parity.  A multi-parity model was considered but may have resulted in biased solutions, 
because cows with high health treatment cost typically leave herds more quickly than 
cows with low health treatment cost.  
RESULTS AND DISCUSSION 
Significance of Effects from Analysis of Intervals 
For the analysis of health treatment cost by interval within lactation, the fixed 
effects of herd, interval, and the interaction of herd and interval were all highly 
significant (P < 0.01) during first parity for each category of health treatment cost, as 
well as TOT.  For second parity, the fixed effects of herd, interval, and the interaction of 
herd and interval were again significant (P < 0.05) for each category of health treatment 
cost and TOT, except not significant (P = 0.59) for the interaction of herd and interval for 
META cost.  For parities 3 to 5, the fixed effect of herd was significant (P < 0.05) for 
each category of health treatment cost, except herd was not significant (P = 0.11) for 
REPRO cost in parity 5.  Interval was significant (P < 0.05) for each category of health 
treatment cost and TOT for third parity, but only for REPRO cost, LAME cost, and TOT 
in fourth parity and only for REPRO cost and TOT in fifth parity.  The interaction of herd 
and interval for third parity was highly significant (P < 0.01) for REPRO cost, LAME 
cost, MISC cost, and TOT but was not significant for MAST and META costs.  For 
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fourth and fifth parity the interaction of herd and interval was significant (P < 0.05) only 
for REPRO cost. 
Health Treatment Cost for Intervals within First Parity 
Least squares means of health treatment cost by category for the 6 lactation 
intervals of first parity are in Table 5, which also provides the percentage of each 
category’s contribution to TOT.  The TOT was significantly higher (P < 0.05) during the 
first interval at $22.87 than all other intervals, and cows accrued the most cost for 
REPRO, META, and MISC during this interval.  The high cost for REPRO and META 
during the first interval was expected, because these categories are primarily comprised 
of treatments for metritis, retained placenta, displaced abomasum, and ketosis, and these 
health disorders most commonly occur near calving (Zwald et al., 2004; Koeck et al., 
2012). 
The REPRO cost during the first interval was mostly metritis treatments that, 
when analyzed separately from other REPRO costs, accrued a mean cost of $9.06.  
Health treatment cost for META during the first interval was mostly because of displaced 
abomasum with a mean cost of $3.02.  In general, REPRO and META costs during the 
first interval of first parity may have been the result of health disorders from the negative 
energy balance that often occurs postpartum (Sundrum, 2015).  Beyond the first interval, 
REPRO cost mainly resulted from treatment for cystic ovaries, mostly during the third 
interval, when this health disorder was uncovered via palpation or ultrasound.  The 
META cost for later intervals was mostly for digestive treatment.  
The high MISC cost during the first interval of first parity is because almost one-
half of the MISC cost was attributed to treatment for elevated temperatures without a 
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specific health disorder being diagnosed.  The treatment of elevated temperature was 
mostly due to the herd health practices of one herd owner.  About one-third of MISC cost 
in later intervals of first parity was for elevated temperatures.  Other MISC cost during 
first parity after the first interval was evenly split between respiratory and injury 
treatments.  
The MAST cost was highest for interval 1 and interval 6 during first parity but 
was evenly distributed across intervals 2 to 5.  The higher MAST cost during the first 
interval is agreement with Appuhamy et al. (2007), who reported a higher incidence of 
mastitis during the first month of lactation than any other time.  A possible reason for the 
elevated MAST cost during the first interval may have been the decreased immune 
response to infection cows often experience during the transition period (LeBlanc, 2010).  
Additionally, Green et al. (2007) indicated poor hygiene causes mastitis during early 
lactation and, perhaps, the high MAST cost for the first interval in this study was due to 
exposure to mastitis-causing pathogens in the heifer rearing or calving facilities.  
Furthermore, the SCC of cows usually increases later in lactation (de Haas et al., 2002), 
and this may explain the high MAST cost near the end of lactation in interval 6. 
The LAME cost was significantly higher (P < 0.05) for intervals 3 and 6 of first 
parity and reflected the timing of routine hoof trimming and the resulting treatment for 
hoof health disorders.  The LAME cost during intervals 3 and 6 in this study is in 
disagreement with Koeck et al. (2012), who reported lameness incidences are evenly 
distributed throughout lactation with slightly higher incidence during early lactation.   
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Health Treatment Cost for Intervals during Later Parities 
 Tables 6 to 9 provide the least squares means of health treatment cost by category 
for the lactation intervals of parities 2, 3, 4, and 5, as well as the percentage of each 
category’s contribution to TOT.  For each parity, TOT was significantly higher during the 
first interval and ranged from $24.69 in second parity to $38.50 in fifth parity.  Across 
parities 2 to 5 the distribution of treatment cost for each health category except MAST 
was similar for individual intervals.  Also, standard errors of treatment cost for each 
health category as well as TOT increased with parity because fewer cows contributed 
data for later parities.  
 The REPRO cost was significantly higher (P < 0.05) during the first interval than 
other intervals for parity 2 to 5.  The high REPRO cost during first interval was expected 
because cows experience transition disorders during this period of time (LeBlanc, 2010).  
The especially high REPRO cost during the first interval of fifth parity was mainly from 
metritis treatments which, when evaluated separately, had a mean cost of $16.87.  Most 
of the REPRO cost after first interval was from treatment for cystic ovaries and, in some 
instances, from additional treatment for metritis.  Metritis may require multiple 
treatments and also may occur at various times during lactation from injury to the 
reproductive tract or from nutritional deficiencies (Hutchinson, 2008).  
The META cost was significantly higher (P < 0.05) during the first interval for 
parities 2, 3, and 4, as it was for first parity, and may have been due to negative energy 
balance after calving (Esposito et al., 2014).  However, META cost for fifth parity was 
evenly distributed across intervals.  For third parity, specifically, the high META cost of 
$12.34 during the first interval was for displaced abomasum, which accrued a mean cost 
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of $8.91 (72% of META cost) for the first interval.  Surgery for displaced abomasum 
during a previous lactation perhaps explains the numerically lower displaced abomasum 
and META cost in fourth and fifth parities.  The META cost after first interval for later 
parities was overwhelmingly due to treatment for digestive disorders.  
 The distribution of MAST cost across the intervals for later parities was different 
from first parity.  For later parities, the proportion of MAST cost during intervals 2 to 5 
was higher than it was in first parity because, in first parity, MAST cost was numerically 
highest for interval 1 and for interval 6.  The difference in distribution of MAST cost 
across intervals for later parities perhaps resulted from preventative treatment for mastitis 
at dry-off during the previous lactation and better management during the pre-fresh 
period for cows than for springing heifers.  
 Similar to first parity results, the LAME cost for parities 2 to 5 was typically 
greatest during interval 3 and interval 6.  The LAME cost during intervals 3 and 6 
reflected the timing of routine hoof trimming that often resulted in hoof treatment, with 
treatment for hoof ulcers accounting for the majority of the LAME cost.  Other than 
during interval 3 and interval 6, LAME cost was usually from treatment for infectious 
pododermatitis.   
Total Health Treatment Cost by Herd and Parity 
 The results from the analysis of THC by herd and parity are in Table 10, and 
standard errors for estimates of THC increased with parity because the number of cows 
declined with parity.  The weighted least squares means of THC of cows based on the 
number of cows in each herd were $54.73, $75.56, $94.43, $100.97, and $122.29 for first 
to fifth parity, respectively.  No previous research has analyzed health treatment costs 
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from commercial dairy herds; however, Becker et al. (2012) analyzed THC of cows in an 
institutional herd of Holsteins and reported a mean THC for first parity of $41.41 and 
$62.41 for cows selected for small and large body size, respectively.  The estimates of 
mean THC from that study are comparable to THC for first parity of herds in this study 
that ranged from $23.38 to $74.60. 
 The mean THC was variable across herds in this study and tended to numerically 
increase from first to third parity for all herds except herd B, which had numerically 
lower REPRO cost in second and third parity than in first parity.  The difference in THC 
between herds is probably a reflection of alternative approaches for addressing the health 
disorders of cows.  Herd owners who more closely monitor fresh cows for transition 
disorders are more likely to detect health disorders, and as a result, may provide 
treatment.  Herd C had the highest THC, numerically, for parities other than for first 
parity, and herd C was more aggressive in treating low-grade disease cases than the other 
herds.  Herd H tended to have low THC for all 5 parities, and we suspect this was a 
reflection of its excellent attention to nutritional requirements and preventative care.  
CONCLUSIONS 
This study was the first to document the cost of health treatments using field data 
from commercial dairies.  Because the data were of high quality, we were able to 
determine the stage of lactation in which health treatment cost was incurred for 5 
categories of health treatment and TOT.  The highest mean TOT was during the first 30 
DIM (interval 1) for all 5 parities and was mainly due to REPRO and META costs.  
Mean MAST cost was highest during interval 1 and interval 6 during first parity but was 
more evenly distributed across intervals for later parities.  The REPRO cost was 
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numerically greatest among the 5 categories for first-parity cows, but in later parities 
MAST cost was generally the highest health treatment cost for cows in the 8 herds.  
Therefore, minimizing REPRO and MAST costs should be a priority of dairy producers 
to enhance profitability.  
Weighted herd means of THC ranged from $54.73 in first parity to $122.29 in 
fifth parity, but THC varied substantially between herds.  This may be a reflection of the 
divergent management strategies and environments of the 8 herds.  Considerable 
variation existed for THC of the 8 herds, but health treatment cost was substantial for the 
majority of the herds.  Reducing the THC of cows in all herds will provide economic 
benefit to dairy producers and, perhaps more importantly, will improve cow welfare. 
Our approach of applying veterinary cost and labor cost to individual health 
treatments permitted the elucidation of the economic effects of alternative health 
disorders.  Also, the method used in this study to supplement incidence of health 
disorders with their cost may provide dairy producers the opportunity to better utilize 
health data for day-to-day management decisions.  Furthermore, resulting data may also 
permit researchers to investigate genetic selection for lower health cost of dairy cows.  
The integrity and uniformity of health data in this study may permit an enhancement of 
genetic variation between daughters of sires for health disorders and, perhaps, to expose 
the genetic control of health traits. 
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Table 1.  Cows and records remaining after each step of data editing   
Edit Cows Records 
Cows with parities 1 to 5 5,052 11,862 
Individual lactations initiated by an abortion 5,052 11,454 
Lacked the opportunity to reach 30 DIM 5,024 11,354 
Cows without first parity 3,224 7,595 
Cows without an AI sire and cows whose AI sire had a single daughter 2,849 6,674 
Cows whose AI maternal grandsire had a single daughter or granddaughter 2,214 4,979 
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Table 2.  Distribution of cows by herd and parity 
 Parity 
Herd 1 2 3 4 5 
A 394 246 125 51 17 
B 227 157 100 44 9 
C 427 299 181 88 43 
D 402 279 150 74 29 
E 179 117 59 15 6 
F 152 105 48 17 5 
G 250 159 66 31 8 
H 183 125 71 30 11 
Total 2,214 1,487 800 350 128 
Percentage  
by parity (%) 
44 30 16 7 3 
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Table 3.  Specific health treatments included in the health categories 
Category Abbreviation Treatment 
Mastitis MAST Mastitis 
  Mastitis diagnostic test1 
   
Lameness LAME Hoof treatment2 
   
Reproduction REPRO Cystic ovaries 
  Retained placenta 
  Metritis 
  Miscellaneous reproduction3 
   
Metabolic META Milk fever 
  Displaced abomasum 
  Ketosis 
  Digestive4 
   
Miscellaneous MISC Respiratory 
  Injury 
  Other treatments 
1 Mastitis diagnostic test included milk culture and California Mastitis Test (Immucell, 
Portland, ME). 
2 Hoof treatment included dermatitis, infectious pododermatitis, foot ulcer, and other hoof 
treatments. 
3 Miscellaneous reproduction included abortion treatments, caesarean section, pyometria, 
uterine disorders (adhesion, mass, prolapse, and torsion), and mummified calf. 
4 Digestive included clostridium, traumatic reticuloperitonitis, hemorrhagic bowel 
  syndrome, peritonitis, twisted cecum, lack of appetite, or any other digestive treatment. 
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Table 4.  Total cost assigned to individual health treatments 
Type of treatment Veterinary cost1 Labor cost2 Total 
 -----------------------($)----------------------- 
Mastitis diagnostic test 8 3 11 
Cystic ovaries 14 2 16 
Digestive 34 10 44 
Displaced abomasum 256 19 275 
Hoof treatment 21 9 30 
Injury 3 23 26 
Ketosis 24 9 33 
Mastitis 22 6 28 
Metritis 112 5 117 
Milk fever 21 17 38 
Miscellaneous reproduction 170 19 189 
Other 25 6 31 
Respiratory 67 10 77 
Retained placenta 75 5 80 
1 Veterinary cost was obtained from the veterinary clinics that serviced the 8 herds. 
2 Fixed labor cost ($18/h) across the 8 herds. 
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Table 5. Least squares means, standard errors, and percentage of total cost (TOT) by category1 of health cost for 6 intervals of lactation of first parity 
 
Health Category 
Interval 
(days in milk) 
MAST REPRO LAME META MISC TOT 
 SE %  SE %  SE %  SE %  SE %  SE % 
 
----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  
1 (0 to 30 d) 2.78a 0.21 12 11.78a 0.47 52 0.84d 0.19 4 3.92a 0.38 17 3.56a 0.23 16 22.87a 0.74 100 
2 (31 to 90 d) 1.55c 0.21 28 0.65b 0.48 11 1.39c 0.19 25 0.89b 0.39 16 1.15b 0.23 20 5.63cd 0.76 100 
3 (91 to 150 d) 1.97bc 0.21 26 1.36b 0.49 18 2.93b 0.20 39 0.39b 0.40 5 0.84bc 0.24 11 7.48c 0.78 100 
4 (151 to 210 d) 1.71bc 0.22 40 0.35b 0.50 8 1.46c 0.20 34 0.47b 0.40 11 0.30c 0.24 7 4.30d 0.79 100 
5 (211 to 270 d) 1.49c 0.22 27 0.28b 0.50 5 1.72c 0.20 31 0.58b 0.41 10 1.48b 0.25 27 5.55cd 0.80 100 
6 (271 d to end) 2.22ab 0.22 22 0.22b 0.50 2 5.84a 0.20 57 0.79b 0.41 8 1.52b 0.25 11 10.23b 0.80 100 
1 MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous.  
a–d Superscripts denote significant differences (P < 0.05) within each health category (column). 
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Table 6.  Least squares means, standard errors, and percentage of total cost (TOT) by category1 of health cost for 6 intervals of lactation for second parity 
 
Health Category 
Interval 
(days in milk) 
MAST REPRO LAME META MISC TOT 
 SE %  SE %  SE %  SE %  SE %  SE % 
 
----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  
1 (0 to 30 d) 1.80c 0.33 7 12.81a 0.63 52 1.18d 0.27 5 5.85a 0.52 24 3.04a 0.29 12 24.69a 1.03 100 
2 (31 to 90 d) 3.09b 0.34 35 0.52bc 0.64 6 2.02c 0.27 22 1.94b 0.54 22 1.39b 0.30 16 8.96c 1.06 100 
3 (91 to 150 d) 4.41a 0.35 32 1.98b 0.66 14 4.30b 0.28 32 1.72b 0.55 13 1.24b 0.31 9 13.65b 1.09 100 
4 (151 to 210 d) 4.21a 0.36 41 1.17bc 0.68 11 2.52c 0.29 25 1.38b 0.56 14 0.91b 0.31 9 10.17c 0.11 100 
5 (211 to 270 d) 3.43ab 0.37 44 0.16bc 0.69 2 2.24c 0.29 29 0.85b 0.57 11 1.04b 0.32 13 7.72c 1.13 100 
6 (271 d to end) 3.03b 0.37 28 0.03c 0.69 0 6.11a 0.29 56 0.64b 0.58 6 1.06b 0.32 10 10.86bc 1.14 100 
1 MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous.  
a–d Superscripts denote significant differences (P < 0.05) within each health category (column). 
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Table 7.  Least squares means, standard errors, and percentage of total cost (TOT) by category1 of health cost for 6 intervals of lactation of third parity 
 
Health Category 
Interval 
(days in milk) 
MAST REPRO LAME META MISC TOT 
 SE %  SE %  SE %  SE %  SE %  SE % 
 
----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  
1 (0 to 30 d) 2.65b 0.53 8 13.36a 0.91 41 1.56c 0.41 5 12.34a 1.09 38 2.88a 0.46 9 32.79a 1.72 100 
2 (31 to 90 d) 5.49a 0.56 49 0.41b 0.96 4 2.36bc 0.43 21  1.83b 1.15 16 1.05b 0.48 9 11.14bc 1.82 100 
3 (91 to 150 d) 5.27a 0.60 32 1.53b 1.02 9 5.18a 0.46 32 2.66b 1.22 16 1.65ab 0.51 10 16.28b 1.93 100 
4 (151 to 210 d) 4.81a 0.61 36 0.70b 1.04 5 2.86b 0.47 22 2.61b 1.25 20 2.32ab 0.52 17 13.31bc 1.97 100 
5 (211 to 270 d) 4.09ab 0.63 46 0.29b 1.07 3 1.96bc 0.48 22 1.68b 1.28 19 0.89b 0.54 10 8.92c 2.03 100 
6 (271 d to end) 2.84b 0.63 22 0.47b 1.07 4 6.38a 0.48 49 1.90b 1.29 15 1.30b 0.54 10 12.89bc 2.04 100 
1 MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous.  
a–c Superscripts denote significant differences (P < 0.05) within each health category (column). 
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Table 8. Least squares means, standard errors, and percentage of total cost (TOT) by category1 of health cost for 6 intervals of lactation of fourth parity 
 
Health Category 
Interval 
(days in milk) 
MAST REPRO LAME META MISC TOT 
 SE %  SE %  SE %  SE %  SE %  SE % 
 
----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  
1 (0 to 30 d) 3.59
b 1.06 12 11.25a 1.56 38 3.00b 0.77 10 8.26a 1.70 28 3.14a 0.67 11 29.25a 2.94 100 
2 (31 to 90 d) 5.22
ab 1.14 33 2.41b 1.67 15 3.74b 0.82 24 3.04b 1.82 19 1.19b 0.72 8 15.60b 3.16 100 
3 (91 to 150 d) 7.05
a 1.25 32 3.41b 1.84 16 7.38a 0.90 34 2.74b 2.00 13 1.21ab 0.79 6 21.79ab 3.46 100 
4 (151 to 210 d) 6.07
ab 1.30 48 0.00b 1.91 0 3.38b 0.94 27 2.23b 2.08 17 1.08ab 0.82 8 12.76b 3.60 100 
5 (211 to 270 d) 4.93
ab 1.34 40 0.09b 1.96 1 3.55b 0.97 29 2.43b 2.14 20 1.35ab 0.85 11 12.35b 3.71 100 
6 (271 d to end) 3.54
ab 1.36 28 0.00b 2.00 0 6.56a 0.98 52 1.39b 2.18 11 1.04ab 0.86 8 12.52b 3.77 100 
1 MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous.  
a–b Superscripts denote significant differences (P < 0.05) within each health category (column). 
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Table 9.  Least squares means, standard errors, and percentage of total cost (TOT) by category1 of health cost for 6 intervals of lactation of fifth parity 
 
Health Category 
Interval 
(days in milk) 
MAST REPRO LAME META MISC TOT 
 SE %  SE %  SE %  SE %  SE %  SE % 
 
----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  ----- ($) -----  
1 (0 to 30 d) 5.47a 1.59 14 20.70a 2.90 54 1.70b 1.08 4 8.16a 2.71 21 2.47a 1.38 6 38.50a 4.97 100 
2 (31 to 90 d) 4.59a 1.82 31 2.19b 3.32 15 2.31b 1.24 16 3.91a 3.10 27 1.71a 1.59 12 14.72b 5.69 100 
3 (91 to 150 d) 6.13a 1.90 34 4.57b 3.47 25 3.63ab 1.30 20 2.10a 3.23 12 1.80a 1.65 10 18.23b 5.94 100 
4 (151 to 210 d) 3.82a 1.95 33 0.00b 3.57 0 2.67ab 1.33 23 2.64a 3.33 23 2.44a 1.70 21 11.58b 6.11 100 
5 (211 to 270 d) 2.27a 2.00 39 0.00b 3.67 0 0.92b 1.37 16 1.06a 3.42 18 1.64a 1.75 28 5.90b 6.28 100 
6 (271 d to end) 4.98a 2.02 33 0.18b 3.69 1 6.03a 1.38 41 3.14a 3.44 21 0.55a 1.76 4 14.88b 6.32 100 
1 MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous.  
a–b Superscripts denote significant differences (P < 0.05) within each health category (column). 
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Table 10.  Least squares means for total health costs (THC) by herd and parity 
 Parity 
 1  2  3  4  5 
Herd  SE   SE   SE   SE   SE 
 -------- $ --------  -------- $ --------  -------- $ --------  -------- $ --------  -------- $ -------- 
A 74.60a 4.11  98.81a 5.99  118.50ab 9.18  100.04bc 16.51  129.18ab 25.22 
B 64.60ab 4.07  50.07d 5.62  58.92cde 8.38  61.82cd 13.70  37.83c 19.31 
C 53.13c 3.95  107.61a 5.43  140.34a 7.63  176.52a 12.57  170.09a 15.86 
D 59.57bc 6.10  75.90bc 8.69  87.29bc 13.36  90.00bcd 30.44  156.17a 42.45 
E 49.76c 5.41  68.47c 7.50  72.69cd 10.26  58.64cd 17.77  30.67c 34.66 
F 64.81abc 6.03  92.70ab 8.40  117.90ab 12.18  114.53b 21.52  123.45ab 31.35 
G 29.79d 5.16  36.11de 7.45  43.55de 12.63  59.61bcd 21.17  23.88c 36.76 
H 23.38d 6.62  26.86e 9.17  27.02e 14.81  21.59d 28.59  25.60bc 46.50 
a–e Superscripts denote significant differences (P < 0.05) between herds within each parity (column). 
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MANUSCRIPT 2 
 
Genetic control of health treatment cost and the correlation of health treatment cost 
with production and conformation of US Holstein cows. 
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INTERPRETIVE SUMMARY 
Health treatments of Holsteins were obtained from producer-recorded health 
records of 8 herds and assigned a fixed cost for veterinary expense and labor.  Heritability 
was estimated for the health treatment cost within 5 health treatment categories.  The 
estimates of heritability were 0.13, 0.04, 0.10, 0.12, and 0.04 for the mastitis, 
reproduction, lameness, metabolic, and miscellaneous categories, respectively, for first 
parity.  The estimates of heritability for total health treatment cost were 0.25 for first, 
0.16 for second, and 0.17 for third parity.  Large genetic correlations were found for total 
health treatment cost with milk production (0.44) and somatic cell score (0.93).  
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MANUSCRIPT 2 ABSTRACT 
 Genetic parameters of health treatment cost were estimated for first (n = 2,214), 
second (n = 1,487), and third (n = 800) parities of US Holstein cows.  The health 
treatments were uniformly defined and consistently recorded by 8 high-performance 
dairy herds in Minnesota from 2008 to 2015.  A fixed treatment cost was assigned to 14 
types of health treatments, and the cost included the mean veterinary expense obtained 
from the veterinary clinics that serviced the 8 herds, from pharmaceuticals, and from 
labor cost.  Farm labor cost was $18/h, and the time incurred for each type of health 
treatment was determined from interviews with the herd owners.  The 14 types of health 
treatment costs were grouped into 5 categories: mastitis (including mastitis diagnostic 
test), reproduction (cystic ovary, retained placenta, and metritis), lameness (hoof 
treatments), metabolic (milk fever, displaced abomasum, ketosis, and digestive), and 
miscellaneous (respiratory, injury, and other).  Health treatment costs for each cow were 
summed by category within lactation and also across categories within lactation.  The 
estimates of heritability for health treatment cost were 0.13, 0.04, 0.10, 0.12, and 0.04 for 
the mastitis, reproduction, lameness, metabolic, and miscellaneous categories, 
respectively, for first parity.  Genetic correlations between categories of health treatment 
cost for first parity were greatest for mastitis and reproduction (r = 0.85 ± 0.20); however, 
phenotypic correlations between all categories were small (r < 0.16).  Total health 
treatment cost had a large genetic correlation with 305-d milk production (0.44 ± 0.18) 
and somatic cell score (0.93 ± 0.13) for first parity.  Also, the genetic correlation (−0.60 ± 
0.16) between total health treatment cost and udder depth for first parity indicated a 
genetic relationship exists between shallow udders and less total health treatment cost.  
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Total health treatment cost across categories had a heritability estimate of 0.25 ± 0.07 for 
first parity, 0.16 ± 0.06 for second parity, and 0.17 ± 0.11 for third parity.  Consequently, 
genetic selection for reduced health treatment cost should be possible by using producer-
recorded health treatment records supplemented with treatment costs.  
 
Keywords: Health treatment cost, Holstein, wellness trait, transition disorder 
 
INTRODUCTION 
 The long-term genetic improvement of production and conformation traits in the 
Holstein breed has negatively affected the health and welfare of dairy cows (Oltenacu 
and Broom, 2010), and the decreased health of cows usually reduces profitability.  The 
total economic cost of health disorders are often not considered by dairy producers, but 
those costs may substantially erode profit per cow for diseased animals.  For example, 
Guard (2008) reported the total cost of a displaced abomasum was $494 and the cost of 
each case of lameness was $469.  Also, health disorders impact the profitability of cows 
through greater involuntary culling, loss of cull cow income from death, decreased milk 
production, and greater milk withholding (Zwald et al., 2004a).  Furthermore, the 
impaired health of cows leads to reduced fertility (Weigel, 2004), and each additional day 
open (d from calving to conception) results in a reduction of $2.75 in profit (VanRaden 
and Cole, 2014).  Consequently, selection for cow health is of growing interest to dairy 
producers.  
 Direct selection against health disorders has been successful in Scandinavian 
countries for more than 30 yr (Philipsson and Lindhé, 2003), because only veterinarians 
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are permitted to treat health disorders and they uniformly record all health treatments for 
cows in a national database.  Also, since the 2000s, several European countries including 
Austria and Germany, have instructed producers to keep accurate and complete records 
of health treatments, which has proven valuable for the genetic evaluation of some health 
disorders (Pryce et al., 2016).  However, in many countries (including the US), the 
recording of health treatments is voluntary, and producer-recorded health data are often 
variable and incomplete.  Low-quality data for health treatments may lack utility for both 
herd management and for genetic evaluation.  However, several North American studies 
have documented the feasibility of using producer-recorded health data to genetically 
improve the health of dairy cows (Zwald et al., 2004a; Koeck et al., 2012; 
Neuenschwander et al., 2012; Parker Gaddis et al., 2014).  
 Estimates of heritability for health traits of dairy cows have generally been low; 
however, the highest estimates have been reported for the health disorders that are most 
frequently recorded due to either their high cost or their ease of recording (Zwald et al., 
2004a; Appuhamy et al., 2009; Neuenschwander et al., 2012).  For example, the 
estimates of heritability for displaced abomasum (from 0.03 to 0.21) and mastitis (from 
0.01 to 0.09) make these particular disorders attractive candidates for genetic selection.  
Despite the typically low estimates of heritability, significant genetic correlations 
between health disorders have been reported (Koeck et al., 2012; Parker Gaddis et al., 
2014; Vukasinovic et al., 2017), including 0.44 for displaced abomasum with metritis 
(Koeck et al., 2012) and 0.56 for retained placenta with metritis (Parker Gaddis et al., 
2014).  Furthermore, Rupp and Boichard (1999) found an antagonistic genetic correlation 
(0.45) between milk production and clinical mastitis.  Mounting evidence suggests 
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selection for greater body size and lower body condition of Holstein cows has been 
detrimental to health of cows.  In particular, a long-term selection study on body size 
reported large Holstein cows had 30% greater cost of health care than small cows (Becker 
et al., 2012).  Furthermore, Dechow et al. (2004) found that dairy form, as a measure of 
angularity, was highly correlated (0.85) with a composite of all health disorders from 
national US data.  
Health disorders have not been included in official genetic evaluation in the US 
because traits with low incidence rates and recorded in a binary fashion present 
challenges for effective selection (Zwald et al., 2004a).  Moreover, Neuenschwander et 
al. (2012) and Parker Gaddis et al. (2012) suggested producer-recorded health data 
require large numbers of cows over multiple years in order to detect reliable differences 
between sires within breeds.  The objective of this study was to estimate genetic 
parameters of health treatment cost (as opposed to binary incidence rates) of Holstein 
cows from producer-recorded health treatments that were uniformly defined and 
consistently recorded in 8 herds over an 8-yr period of time. 
MATERIALS AND METHODS 
Experimental Design 
 A long-term study of Holstein cows in 8 high-performance herds in Minnesota 
was initiated by the University of Minnesota in 2008.  In June 2016, the weighted mean 
production for all cows in the 8 herds was 14,019 kg of milk, 519 kg of fat, 433 kg of 
protein, and the herds ranged in size from 302 to 1,932 cows with a mean herd size of 
981 cows; however, some cows in the herds were not Holstein.  All cows in each of the 8 
herds were housed in a 4- or 6-row freestall facility and fed a TMR during lactation. 
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 Cows were mated to only proven AI bulls with very high rank for Net Merit 
(VanRaden and Cole, 2014), and the bulls were chosen by the herd owners in 
consultation with 2 genetic advisors employed by Minnesota Select Sires Co-op, Inc., St. 
Cloud, MN.  Herd owners were asked to select proven AI bulls that ranked among the top 
10% of available bulls for the Net Merit index within the Holstein breed.  Also, some of 
the pure Holstein heifers and cows were mated to proven AI bulls from the Montbeliarde 
and Viking Red breeds, but those progeny were not included in this study.  Following 
selection of AI bulls, cows were correctively mated by the 2 genetic advisors for 
conformation and heifers were correctively mated, when possible, using the conformation 
scores of their dam.  Also, inbreeding protection was provided for matings of Holstein AI 
bulls to Holstein cows and heifers.  
Experimental Units 
 Only the first 3 lactations of 4,894 Holstein cows across the 8 herds were 
considered for the study.  Cows initiated a first lactation from March 2008 to October 
2015 and were required to calve for a first time during this time span in order to 
contribute data for second and third parity.  Data for this study included 287 cows that 
had not completed first, 218 cows that had not completed second, and 109 cows that had 
not completed third lactation by the end of the study (November, 2015).  Lactations of 
cows commenced with an abortion (n = 267) were removed from the analysis.  Also, the 
lactations of cows that calved during the final month of the study (n = 77) did not have 
the opportunity to accumulate 30 d of health treatment cost and were removed from the 
data. 
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 All cows and their dams were required to be sired by a Holstein AI bull that had a 
sire code assigned by the National Association of Animal Breeders (Columbia, MO).  
Additional edits eliminated cows with sires that had only a single daughter and with 
maternal grandsires that had only a single daughter or granddaughter.  The edits that were 
based on pedigree of cows were applied to improve the accuracy of sire and maternal 
grandsire identification.  Following all edits, 2,214 cows sired by 260 AI bulls remained 
for analysis and a total of 4,501 lactations were analyzed.  The distribution of cows by 
herd and parity is in Table 1. 
Trait Descriptions 
 Health Treatments.  The treatment of 14 individual health disorders (Table 2) 
were uniformly defined and consistently recorded across the 8 herds with Dairy Comp 
305 (Valley Ag Software, Tulare, CA).  To distinguish between multiple treatments of 
the same illness event during the lactation of each cow, a new health treatment 
observation was assigned only if 3 or more days elapsed between hoof treatments, if 5 or 
more days elapsed between digestive, ketosis, mastitis, metritis, milk fever, and 
respiratory treatments, or if 7 or more days elapsed between cystic ovary treatments.  
Only a single treatment observation was permitted per lactation of a cow for displaced 
abomasum, retained placenta, and miscellaneous reproduction.  No restriction on days 
between treatments was applied to mastitis diagnostic test, injury, or other treatments; 
however, only 1 treatment per day was permitted.  The health treatments were assigned to 
1 of 5 categories: mastitis (MAST), reproduction (REPRO), lameness (LAME), 
metabolic (META), and miscellaneous (MISC), which are itemized in Table 2. 
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 A fixed cost was calculated for each of the 14 types of health treatments, and cost 
was the sum of veterinary expense, pharmaceuticals, and labor cost associated with each 
specific type of treatment.  Veterinary expenses and pharmaceutical costs were the mean 
costs for each treatment reported by the veterinarians that serviced the 8 herds.  Labor 
cost included the time required by herd owners for segregation, restraint, and therapy and 
was assigned a value of $18/h.  The hourly rate and the time attributed to each type of 
health treatment was the mean rate and time reported during interviews of the 8 herd 
owners.   
  The observations for health treatment cost of each cow were summed within each 
of the 5 health categories by parity (including the subsequent dry period) to obtain a 
lactational cost for MAST, REPRO, LAME, META, and MISC.  Likewise, the costs of 4 
specific health treatments (displaced abomasum, ketosis, metritis, and retained placenta) 
were summed by treatment type and by parity for each cow.  Finally, health treatment 
cost across all 14 treatment types was summed to obtain the total health cost (THC) by 
parity for individual cows.  For cows that left the herd during lactation, THC was simply 
the sum of health costs from calving until the day of disposal and no adjustment was 
made for DIM at disposal.  Likewise, for cows with records in progress at the end of the 
study (n = 614), THC for that parity was the sum of health costs incurred from calving 
until the end of the study.  
 Production and SCS.  Best Prediction (Cole and VanRaden, 2009), which is 
routinely used for genetic evaluation in the US, was applied to individual test-day 
observations to calculate the actual 305-d milk, fat, and protein production (not mature 
equivalent production) as well as SCS of cows for their first 3 lactations.  Five of the 8 
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herds had monthly test-day observations, and the other 3 herds had test-day observations 
at least 8 times per yr.  Test-days were required to be at least 4 DIM and milk weights 
were required to be greater than 2.27 kg, fat percentage was required to be at least 1.0% 
but no greater than 9.9%, and protein percentage was required to be at least 1.0% but no 
greater than 6.0%.  Best Prediction adjusted records for age at first calving and projected 
records to 305 d for records less than 305 d.  Some cows left herds prior to a first test 
day; therefore, a total of 2,155 first parity, 1,466 second parity, and 757 third parity 
records were available for analysis. 
 Conformation. Conformation of cows was scored once during first lactation by 1 
of 2 evaluators employed by Minnesota Select Sires Co-op, Inc., St. Cloud, MN.  Three 
conformation traits (stature, dairy form, and udder depth) were analyzed for this study 
and were subjectively scored on a 1-to-9 linear scale with a score of 5 representing the 
biological mid-point for each trait (Select Sires, Inc., Plain City, OH).  Most cows were 
scored in early lactation (32 ± 0.3 DIM).  Stature was scored, but not measured, at the 
withers and each unit on the 1 to 9 scale represented approximately 2.54 cm of height.  
Cows with a score of 1 were less than 130 cm and cows with a score of 9 were greater 
than 150 cm.  For dairy form, a score of 1 represented heavy, coarse-boned cows that 
lacked openness of rib, whereas 9 represented clean, open-ribbed, long-necked cows.  
Udder depth described the position of the udder floor relative to the hocks and each unit 
on the 1 to 9 scale represented approximately 2.54 cm.  Cows with a score of 1 had udder 
depth at least 5 cm below the point of the hock, and cows with a score of 9 had udder 
depth at least 15 cm above the point of the hock.  Some cows either left the herds prior to 
 65 
 
 
scoring or were not scored; therefore, conformation was analyzed for 2,090 first-parity 
cows. 
Genetic Analysis  
 Linear animal models ignoring the pedigree for maternal granddams of cows were 
fitted using restricted maximum likelihood (ASReml; Gilmour et al., 2015).  Pedigrees of 
the Holstein cows were provided by the Council on Dairy Cattle Breeding (Bowie, MD); 
however, only relationships among sires and maternal grandsires of cows were used for 
analysis.  All models included the fixed effect of herd and cow nested within herd was a 
random variable.  A preliminary analysis examined the fixed effects of year and season of 
calving; however, neither effect significantly accounted for variation of the dependent 
variables. 
 Three distinct statistical models were used for analysis.  First, a univariate linear 
model was fitted to obtain least squares means, estimates of heritability, and standard 
errors for health treatment cost for each of the 5 health treatment categories, THC, the 4 
specific health treatment costs, and the 3 conformation traits for only first parity.  The 
second was a bivariate linear model, which was fitted to obtain pairwise genetic and 
phenotypic correlations between the 5 categories of health treatment cost, THC, 4 
specific health treatment costs, 305-d production, and conformation for only first parity.  
Correlations were obtained in a pairwise manner because convergence of a multitrait 
model including all dependent variables simultaneously was not feasible with ASReml.  
Lastly, a multivariate linear model was fitted to obtain least squares means, estimates of 
heritability, and standard errors for THC, 305-d production, and SCS during first, second, 
and third parity.  For this model, each of the dependent variables were analyzed 
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separately and each of the 3 parities were defined as 3 distinct traits in the multivariate 
model. 
RESULTS AND DISCUSSION 
Least Squares Means   
 The mean cost for 5 categories of health treatment, THC, and mean cost for 4 
specific health treatments (Table 3) were generated by the univariate analysis that 
included only a single parity for Holstein cows.  The REPRO had the highest percentage 
contribution (28%) to THC and a first-parity cost of $15.28.  The cost of REPRO mostly 
reflected treatment cost for metritis, which had a cost of $9.95.  Also, LAME (23%) and 
MAST (20%) contributed greatly to THC with cost of $12.89 and $10.88, respectively.  
Donnelly et al. (2017) analyzed the costs of health treatments subdivided by 6 intervals of 
lactation and found the treatment costs for REPRO, META, and MISC were more 
concentrated during early lactation, while treatment costs for MAST and LAME were 
distributed throughout first lactation.  In that study, 41% of THC during first parity 
occurred during the first 30 d of lactation. 
 The means for the 3 conformation traits for first parity conformed to expectation 
for young Holstein cows in early lactation (Table 3).  The score of 5.6 for stature (on a 9-
point scale) converts to approximately 141 cm of stature at the withers (Select Sires, Inc., 
Plain City, OH).  For dairy form, the least squares mean of 5.4 indicated these first-parity 
cows in early lactation were slightly more angular than the biological midpoint for dairy 
form.  First-parity cows in this study had mean udder depth of 6.7, which indicated that 
the average cow had an udder floor approximately 9 cm above the point of hock.  
Shallow udders for first-parity Holsteins were also reported in a French study by Rupp 
 67 
 
 
and Boichard (1999) and were also scored on a similar 9-point scale with an average 
score of 6.3 for udder depth. 
 The multivariate analysis was used to fit means for THC across the first 3 parities 
(Table 4), and the mean THC for first parity from that analysis differed by only $2.73 
from the univariate analysis.  The least squares means for THC from the multivariate 
analysis increased with parity (Table 4) and ranged from $57.91 for first parity to $87.95 
for third parity.  The THC observed for first parity in this study may not seem expensive 
on a per-cow basis; however, the average herd in this study calved 444 first-parity cows 
during 2015, which amounts to at least $25,000 annually in THC.  Furthermore, the 8 
herds had more multiparous than primiparous cows; therefore, the economic impact of 
THC for these 8 herds was substantial and may greatly impact profitability. 
 The least squares means for production traits for parities 1 to 3 (Table 4) were 
also calculated from the multivariate analysis, and the means fit expectations for the high 
performance of these 8 herds.  The least squares means for milk, fat, protein, and fat plus 
protein production increased with parity, and the milk production of cows in this study 
was far superior to the average fluid milk production (10,157 kg) of cows enrolled in 
milk recording across the US during 2015 (US Department of Agriculture, 2016).  
Furthermore, the means of SCS were similar to the average SCS for first (2.2), second 
(2.4), and third and greater (3.0) parity of US Holstein herds enrolled in milk recording 
(Dairy Records Management System, 2016). 
Estimates of Heritability for Health Treatment Cost in First Parity   
 Heritability was estimated for the 5 categories of health treatment cost and also 
for THC with a univariate analysis that only considered first parity of cows and is in 
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Table 5.  The estimate of heritability (0.13) for cost of MAST was higher than the 
estimates of heritability of 0.06 and 0.09 reported by Gernand et al. (2012) and Zwald et 
al. (2004a), respectively.  The estimate of heritability for cost of MAST in this study 
supports the suggestion of Nash et al. (2000) and Zwald et al. (2004a) to include both 
mastitis and SCS in a selection index to improve the effectiveness of selection for 
mastitis resistance.   
 The estimate of heritability (0.04) for cost of REPRO in first parity (Table 5) was 
low and not significantly different from zero.  Previous studies have reported similarly 
low estimates of heritability (0.02) for the incidence of reproduction disorders across 
parities (Lyons et al., 1991; Dechow et al., 2004).  The health treatment cost for metritis 
and retained placenta (Table 6) had estimates of heritability of 0.02 and 0.12, 
respectively, and both of these individual health treatment costs were included for the 
cost of REPRO.  The estimate of heritability of metritis cost in this study was similar to 
the estimates of heritability (0.01 to 0.04) from 3 other reports (Van Dorp et al., 1998 and 
Koeck et al., 2012, Parker Gaddis et al., 2014).  However, the estimate of heritability 
(0.12) for cost of retained placenta in this study was smaller than the heritability (0.22) 
reported by Parker Gaddis et al. (2014), but larger than the estimate of heritability (0.07) 
recently reported by Vukasinovic et al. (2017) from a large, producer-recorded data file 
in the US.  A possible explanation for the different estimates of heritability for retained 
placenta across studies may be due to differences in the clear distinction of treatment for 
retained placenta and treatment for metritis, because treatments for these two 
reproductive disorders are sometimes recorded as a single disorder.  The estimates of 
heritability in this study suggest the cost of retained placenta is a superior selection 
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criterion to the categorical cost of all REPRO treatments because large variation existed 
for the cost of metritis and other costs of specific health treatments summed within 
REPRO. 
 The estimate of heritability of 0.10 for cost of LAME in this study (Table 5) is 
within the range of estimates (0.02 to 0.23) for incidence of specific types of hoof health 
disorders for Holstein cows in Nordic countries (Häggman and Juga, 2013; Ødegård et 
al., 2013).  Hoof health data recorded by professional hoof trimmers in Nordic countries 
was the foundation for the development of a hoof health selection index, which was 
integrated into the Nordic total merit index in 2011 (Johansson et al., 2011).  Genetic 
evaluation of hoof health disorders using data recorded by hoof trimmers has also been 
explored in other regions of the world including Canada (Chapinal et al., 2013), Spain 
(Pérez-Cabal and Charfeddine, 2015), and the Netherlands (van der Linde et al., 2010).  
The estimate for cost of LAME in this study suggests selection for reduced cost of 
lameness of dairy cattle is possible when treatments for LAME are routinely recorded.   
Selection for reduced lameness may increase the profitability of cows; however, the 
consequential improvement of welfare of cows may be even more valuable into the 
future.  
 The cost of META had an estimate of heritability of 0.12 for first parity (Table 5), 
which was higher than the estimate of 0.05 reported by Gernand et al. (2012), but lower 
than the estimate of 0.17 from Lyons et al. (1991) for incidence of metabolic disorders.  
Displaced abomasum accounted for 61% of the cost of META (Table 3) and had an 
estimate of heritability of 0.12 (Table 5) for first parity.  The heritability of displaced 
abomasum cost in the present study was in agreement with the estimate of heritability 
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(0.12) for incidence of displaced abomasum reported by Parker Gaddis et al. (2014), but 
higher than estimates of 0.08 and 0.09 reported for incidence of displaced abomasum by 
Dechow et al. (2004) and Abdel-Azim et al. (2005), respectively.  Ketosis also 
contributed to cost of META cost in this study, and ketosis had an estimate of heritability 
of 0.18 when evaluated as a specific health treatment (Table 6).  Our estimate of 
heritability (0.18) for ketosis cost was greater than the estimates ranging from 0.01 and 
0.14 for incidence of ketosis in Holstein cows reported by the 10 studies reviewed by 
Pryce et al. (2016).  Donnelly et al. (2017) described the substantial treatment costs for 
specific health disorders (especially displaced abomasum) included in META for this 
study; however, the incidence of treatments for META is apparently low because the cost 
of META was only 15% of THC (Table 3).  Therefore, selection against META cost may 
substantially reduce health costs even though a small percentage of cows have metabolic 
disorders because of the high cost associated with each treatment of META. 
 The low estimate of heritability (0.04) for MISC cost for first parity was not 
significantly different from zero.  Reports of heritability for respiratory disorders are 
sparse in the literature; however, Lyons et al. (1991) estimated heritability of 0.01 for 
respiratory disorders.  Few injured cows experience treatment because most cows either 
recover without intervention or exit the herd without treatment when an injury is 
catastrophic.  Therefore, results from this study suggested treatments for injury were 
highly dependent on environmental factors.  Therefore, the low heritability (0.04) for cost 
of MISC in this study was anticipated because of the lack of uniform treatment types 
within the MISC category. 
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  This study summed the cost of all disorders for a lactation, which permitted a 
comprehensive consideration of the genetic control of health disorders, and this is 
contrary to a majority of studies that used field data to estimate genetic parameters for 
incidence of health treatments recorded in a binary manner (Harder et al., 2006; Koeck et 
al., 2012; Parker Gaddis et al., 2014; Vukasinovic et al., 2017).  Previous research with 
incidence data typically gave estimates of heritability for health disorders that were less 
than 0.10; however, the estimate of heritability (0.27) for THC from this study was 
moderate for first parity (Table 5), despite the lower estimates for each of the 5 treatment 
categories.  The higher estimate of heritability (0.27) found in this study compared with 
previous research likely resulted from greater variation for THC between cows.  
Variation in THC in this study may have resulted from the assignment of variable costs 
for 14 specific health treatments, from permitting treatment incidence of some disorders 
to be recorded more than once per lactation, or from both.  Apparently, sires that 
transmitted genes to their daughters that resulted in greater cost of health disorders were 
more readily exposed when cost of treatments were combined compared to analyses in 
which incidence of health treatments were combined.  Few studies have summed 
incidence or cost of health treatments within a lactation; however, Lyons et al. (1991) 
estimated a heritability of 0.03 for the sum of all health incidences weighted by their 
costs and pooled across lactations. 
Estimates of Heritability for Conformation  
 The heritability estimate (0.42 ± 0.08) for stature was the highest of the 3 
conformation traits, and this was expected because previous studies also reported stature 
had the highest heritability among commonly reported conformation traits (DeGroot et 
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al., 2002; Dechow et al., 2003).  The estimate of heritability for dairy form and udder 
depth for first parity was 0.28 ± 0.06 and 0.32 ± 0.07, respectively.  Dechow et al. (2003) 
reported estimates of heritability of 0.37 for stature and 0.24 for dairy form, which are 
similar to the estimates in this study.  However, Van Dorp et al. (1998) found a much 
lower estimate of heritability for udder depth (0.19).  Nonetheless, the heritability 
estimates from this study are in general agreement with those published by Holstein 
Association USA (2016), which were 0.42, 0.29, and 0.28 for stature, dairy form, and 
udder depth, respectively.  
Genetic and Phenotypic Correlations for First Parity 
 Health Categories and THC.  Positive genetic correlations were found among all 
combinations of the 5 categories of health treatment costs for first-parity cows (Table 5).  
Clearly, genetic predisposition for health treatment cost in one category was accompanied 
by greater likelihood of health treatment cost in other categories.  The genetic correlation 
(0.85) between the costs of MAST and REPRO was particularly large, and the estimate 
from this study was greater than the genetic correlations between mastitis and specific 
types of reproduction disorders reported by Koeck et al. (2012) and Parker Gaddis et al. 
(2014).  The genetic correlation (0.73) between the costs of REPRO and META was also 
substantial and greater than estimates of genetic correlation (-0.21 to 0.42) between the 
incidence of similar types of health disorders reported by Zwald et al. (2004b), Koeck et 
al. (2012), and Parker Gaddis et al (2014).  
 Genetic correlations between THC and health treatment cost for each of the 5 
categories (Table 5) were all highly positive and ranged from 0.65 (THC with LAME) to 
0.92 (THC with MAST).  The correlations of THC with the cost of REPRO (r = 0.91) 
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and THC with the cost of MISC (r = 0.72) were not different from unity for first parity 
because the SE for both correlations were large; therefore, we believe selection for THC 
may be more effective for lowering the cost of REPRO and MISC than direct selection 
for only cost of REPRO and MISC, which both had low and non-significant estimates of 
heritability. 
 The phenotypic correlations among the 5 categories of health treatment cost were 
much smaller than the genetic correlations and ranged from −0.05 (MISC with LAME) to 
0.16 (MISC with META).  Phenotypically, cows with more META cost were more prone 
to higher costs of REPRO (r = 0.14) and MISC (r = 0.16).  Metabolic disorders, 
especially ketosis, have been associated with an increase of other infectious diseases and 
impaired reproduction in other reports (Reist et al. 2003; Walsh et al., 2007); therefore, 
the significant phenotypic relationship between the costs of REPRO and META in this 
study was not surprising.  Among commercial herds in New York, cows with retained 
placenta had increased risk of developing mastitis (Schukken et al., 1988).  However, our 
study found no phenotypic correlation (0.00) between the costs of REPRO and MAST for 
first parity.  Phenotypic correlations between THC and the health treatment cost of the 5 
categories ranged from 0.27 (LAME) to 0.66 (REPRO).  Costs of REPRO and META 
had the largest phenotypic correlations (0.66 and 0.63, respectively) with THC.  The 
individual treatments with highest cost were found within these 2 categories (Donnelly et 
al., 2017), which may partially explain their strong phenotypic correlation with the total 
costs of health treatment for first-parity cows.  Furthermore, a moderate phenotypic 
correlation (0.34) existed between THC and the cost of MAST, which confirmed the 
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result of Hansen et al. (2002), who reported cows with mastitis are more likely to 
experience other health disorders. 
 Four Specific Health Treatments.  For first parity, the costs of displaced 
abomasum and ketosis had a genetic correlation (0.97) near unity (Table 6), which 
indicated genes influencing treatment for displaced abomasum were likely the same 
genes influencing treatment of ketosis.  Similarly, the genes associated with treatment 
costs of retained placenta and ketosis (r = 0.88) may be mostly the same.  Also, the 
genetic correlation (0.79) for costs of metritis and displaced abomasum was likely the 
explanation for the large genetic correlation (0.73) between the categorical costs of 
REPRO and META (Table 5). 
 Four of the 5 phenotypic correlations estimated among the costs for the specific 
health treatments (Table 6) were significantly greater than zero.  Apparently, some cows 
treated for a first health disorder postpartum experienced a second (or multiple) health 
disorders postpartum.  The phenotypic correlation (0.24) for ketosis and displaced 
abomasum is comparable to the correlation of 0.27 among the same 2 traits for Holstein 
cows in a study of Canadian commercial herds (Koeck et al., 2012).  A study by LeBlanc 
et al. (2005) reported postpartum negative energy balance may lead to a metabolic 
disorder, such as ketosis, which is a risk factor for displaced abomasum.  The low 
phenotypic correlations between the cost of specific health treatments in this study agree 
closely with the correlations between incidences of health disorders from other studies 
(Van Dorp et al., 1998; Koeck et al., 2012), and this is likely because treatments of 
retained placenta and displaced abomasum occurred once per lactation and none of these 
traits were grouped with other disorders for analysis.  
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 THC and Production Traits.  The genetic correlation (0.44) of THC with 305-d 
milk production was especially unfavorable (Table 7) and provided evidence that the 
simultaneous selection for lower health cost in conjunction with selection for milk 
production is very important.  Lyons et al. (1991) reported a smaller genetic correlation 
(0.29) between milk production and the sum of all health incidences.  In the current 
study, fat, protein, and fat plus protein production also had unfavorable genetic 
correlations with THC, but they were smaller and not significantly different from zero.  
Perhaps, selection for the solids constituents in milk is not as detrimental to cow health as 
the historical selection for fluid milk.  The genetic correlation (0.93) of THC with SCS 
was large, and Täubert et al. (2013) reported a large genetic correlation (0.76) of SCS 
with incidence of mastitis.  More than likely, the dramatic genetic trend for reduced SCS 
in the US since 2001 (Council on Dairy Cattle Breeding, 2016) has reduced THC of the 
Holstein breed during the last 15 yr.   
 Phenotypic correlations between THC and production traits (Table 7) were 
negative and small.  Cows with more health problems and consequently, greater THC, 
had decreased 305-d production of milk, fat, protein, and fat plus protein.  Other studies 
also found a slightly negative relationship between health disorders and production 
(Fourichon et al., 1999; Gernand et al., 2012).  A small and positive phenotypic 
correlation (0.14) between SCS and THC in this study was similar to the 0.22 phenotypic 
correlation reported by Täubert et al. (2013).  Cows with high SCS are expected to have 
more THC because higher SCS often accompanies greater cost of MAST.   
 Health Treatment Cost and Conformation.  None of the genetic correlations of 
health treatment cost for the 5 categories, THC, and 4 specific health treatments with 
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stature and dairy form (Table 8) were significantly different from zero because the 
standard errors were large.  These results are contrary to Dechow et al. (2004), who 
reported a large, antagonistic genetic association of 0.85 between dairy form and a 
composite of all diseases recorded in US dairy herds.  The large, but not significant, 
genetic correlations of stature and dairy form with health treatment cost are likely a 
reflection of scoring of the cows for stature and dairy form only once in early lactation in 
this study resulting in little variation (SE = 0.14 and 0.16; Table 3).  Therefore, statistical 
models may have had difficulty detecting the underlying genetic relationships.  The 
addition of observations for conformation traits during late lactation and from 
multiparous cows (e.g., Dechow et al., 2004) would provide more phenotypic variation to 
permit elucidation of genetic relationships.   
 The phenotypic correlations of both stature and dairy form with health treatment 
costs for each of the 5 categories were small (Table 8); however, some were significantly 
different from zero.  Small phenotypic correlations between the conformation traits and 
health disorders were also reported by Lund et al. (1994) and Van Dorp et al. (1998).  
Taller cows in this study were associated with greater cost of MAST (r = 0.04), LAME (r 
= 0.04), and META (r = 0.04).  Furthermore, taller cows were associated with increased 
displaced abomasum.  A long-term selection study on body size of Holsteins (Becker et 
al., 2012) found cows in a large body size line had 2.6 times the incidence of displaced 
abomasum as cows in a small body size line for first parity and more than 4 times the 
incidence of small-line cows for second parity.  The large body size line had double the 
treatment cost for displaced abomasum compared with the small body size line (Becker et 
al., 2012).   
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 Phenotypically, cows with more dairy form and, therefore, lower BCS (Dechow et 
al., 2003) were associated with higher costs of REPRO (r = 0.04) and also greater THC (r 
= 0.05) in the present study.  Others (Hansen et al., 2002; Dechow et al., 2004) have 
hypothesized that the mechanism of causation lies in the association of high dairy form 
with negative energy balance that is typical for periparturient Holstein cows.  Negative 
energy balance causes a depressed immune system (Goff and Horst, 1997), which could 
lead to more cost for health treatments—especially for postpartum metabolic disorders 
but also for some infectious diseases. 
 The genetic correlation (−0.60) of udder depth with THC indicated bulls 
transmitting shallower udders also transmitted lower cost of health treatments (Table 8).  
Perhaps, this genetic relationship was because cost of MAST had the largest genetic 
correlation (−0.84) among health treatment categories with udder depth.  Rupp and 
Boichard (1999) reported a more modest genetic correlation (−0.26) between udder depth 
and incidence of mastitis.  Furthermore, udder depth had a significant genetic correlation 
(−0.65) with REPRO cost.  The favorable genetic relationships of udder depth with lower 
cost of MAST, REPRO, and THC may result from concurrent genetic selection for udder 
depth, SCS, and fertility.  The phenotypic correlation (−0.11) between udder depth and 
MAST cost indicated cows with shallower udders had lower MAST cost.  Udders closer 
to the ground may have functional problems while milking or may have more contact 
with bedding in stalls (Hansen et al., 1999).  Therefore, the relationship of udder depth 
and MAST cost may be a result of only extremely deep udder depth and not a result of 
extremely shallow udder depth.  However, the EBV for stature and udder depth have a 
large genetic correlation (DeGroot et al., 2002); therefore, inclusion of udder depth in 
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selection indexes as an indicator of reduced MAST cost in the US and internationally 
must be done with care to avoid a corresponding increase of stature.  
Heritability of THC and Production Traits for Multiple Parities 
 The estimated heritability (0.25) of THC for first parity from the multivariate 
analysis (Table 9) was similar to the heritability (0.27) from the univariate analysis; 
however, both estimates were remarkably high compared to previous estimates of 
heritability for health traits.  The estimates of heritability for THC for second (0.16) and 
third (0.17) parity were more modest than the result for first parity.  The decrease in 
heritability of THC with increasing parity may result from the reduced number of cows 
contributing to the estimates and the removal (culling) of cows with greater THC from 
parity to parity.  Cows with lower first-parity THC are more likely to remain for second 
and third parity.  Zwald et al. (2004a) also reported higher heritability of health traits for 
first-parity cows than for multiparous cows, and they attributed this result to decreased 
genetic variance or increased residual variance from environmental factors such as poor 
management during the previous dry period.  Our results suggest substantial genetic 
control for THC for all 3 parities.  Therefore, because of the negative impact of THC on 
cow profitability, selection against THC should provide substantial economic gain for 
dairy producers.  
 Estimates of heritability for the production traits (Table 9) were similar to those 
used for routine genetic evaluation of US Holstein cows (VanRaden and Cole, 2014) for 
the production traits (h2 = 0.20) and for SCS (h2 = 0.12).  However, estimates of 
heritability for 305-d production for first parity from this study were lower than the 
estimates reported by Rupp and Boichard (1999) of 0.26, 0.31, and 0.26 for milk, fat, and 
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protein production, respectively, for French Holstein cows.  The heritability (0.18) for 
SCS in this study is in agreement with the estimate of heritability (0.17) of Van Dorp et 
al. (1998).   
 Moderate heritabilities for production traits of dairy cattle have permitted 
substantial improvement in production over the past 50 years.  The heritability of THC in 
this study suggests substantial improvement should likewise be possible for reducing 
health treatment cost of dairy cows if health treatments are recorded in a uniform manner 
on farms for the most common and most expensive health disorders. 
Prediction of Breeding Values 
 The EBV for THC of sires (n = 53) with at least 10 daughters from the univariate 
analysis of first-parity cows are plotted versus the mean THC of the corresponding 
daughters (Figure 1).  The EBV for THC ranged from $67 to −$49, and this is a 
difference of roughly $116 between the highest and lowest for first-parity THC.  
However, most of the sires had EBV for THC between $20 and −$40.  The regression 
coefficient was 0.92, which indicated the EBV for THC of sires were very good 
predictors of the extent of THC for their daughters.  The range of EBV for THC suggests 
sire selection could be highly effective in successfully reducing the THC of dairy cows. 
CONCLUSIONS 
 The genetic evaluation of health traits for dairy cows in the US has been inhibited 
by inconsistent and incomplete health data because producers in the US are not 
incentivized or required to record health events.  Most previous efforts to estimate genetic 
parameters of health traits had observations limited to the recording of a single binary 
outcome per disorder for each parity.  The comprehensive recording of health data by the 
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8 herds in this study permitted the application of health treatment costs on the 14 
different types of treatment and also enabled inclusion of multiple treatments per 
lactation for genetic analysis.  These two factors provided greater expression of genetic 
variation and may have furnished a more appropriate data structure than binary data for a 
genetic analysis of health disorders. 
 Genetic correlations between THC and health treatment cost for each of the 5 
treatment categories were large and positive for first parity.  The moderate genetic 
correlation between THC and 305-d milk production for first parity suggested historical 
selection for increased fluid milk production may have caused a correlated increase of 
THC in modern Holstein cows; however, our results suggest selection for fat (kg) and 
protein (kg) has a reduced association with THC. 
 Results from this study indicate the collection of uniform and comprehensive 
health treatment data in the US is potentially feasible using current herd management 
software.  However, the EBV for THC of dairy cattle must be included in a selection 
index with appropriate economic weights that have taken into account the relationship of 
THC with other traits included in the selection index.  Selection for reduced THC should 
lessen the chances of antibiotic residues in meat and milk and should lead to the 
enhanced welfare of cows and an improved public perception of the dairy industry. 
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Table 1.  Numbers of cows analyzed for cost of health treatments by herd and 
parity 
 Parity 
Herd 1 2 3 
A 394 246 125 
B 227 157 100 
C 427 299 181 
D 402 279 150 
E 179 117 59 
F 152 105 48 
G 250 159 66 
H 183 125 71 
Total 2,214 1,487 800 
Percentage of 
total by parity (%) 
49 33 18 
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Table 2.  Specific health treatments included in the health treatment categories 
Category Abbreviation Treatment 
Mastitis MAST Mastitis  
  Mastitis diagnostic test1 
   
Lameness LAME Hoof treatment2 
   
Reproduction REPRO Cystic ovaries 
  Retained placenta 
  Metritis 
  Miscellaneous 
reproduction3 
   
Metabolic META Milk fever 
  Displaced abomasum 
  Ketosis 
  Digestive4 
   
Miscellaneous MISC Respiratory 
  Injury 
  Other treatments 
1 Mastitis diagnostic test included milk culture and California Mastitis Test (Immucell, 
Portland, ME). 
2 Hoof treatment included dermatitis, infectious pododermatitis, foot ulcer, and other hoof 
treatments.  
3 Miscellaneous reproduction included abortion treatments, caesarean section, pyometria, 
uterine disorders (adhesion, mass, prolapse, and torsion), and mummified calf. 
4 Digestive included clostridium, traumatic reticuloperitonitis, hemorrhagic bowel 
syndrome, peritonitis, twisted cecum, lack of appetite, or any other digestive treatment. 
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Table 3.  Least squares means, standard errors, and percent of total health cost 
(THC) for the treatment costs of 5 health categories, THC, 4 specific health 
treatments, and the average conformation scores (1 to 9 scale) for first parity from 
univariate analysis 
Trait LSM SE 
Percentage 
of total 
Category1 ------------($)------------ (%) 
 MAST 10.88 2.36 20 
 REPRO 15.28 4.54 28 
 LAME 12.89 2.13 23 
 META 8.02 3.82 15 
 MISC 8.13 2.28 15 
THC 55.18 7.89 100 
Specific health treatment    
 Metritis 9.95 3.53 18 
 Retained placenta 2.12 1.22 4 
 Displaced abomasum 4.91 3.33 9 
 Ketosis 0.60 0.42 1 
    
Conformation  ---------Score---------  
 Stature 5.6 0.14 -- 
 Dairy form 5.4 0.16 -- 
 Udder depth 6.7 0.13 -- 
1  MAST = mastitis, REPRO = reproduction, LAME = lameness, META =  
 metabolic, and MISC = miscellaneous. 
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Table 4.  Least squares means and pooled SE for total health treatment cost (THC),  
305-d production, and SCS for parities 1 to 3 from multivariate analysis across parities 
  Parity   
Trait 1 2 3 Pooled SE 
THC ($) 57.91 73.92 87.95 13.95 
Milk (kg) 10,943 12,628 13,018 261 
Fat (kg) 395 449 464 9.5 
Protein (kg) 332 389 401 7.1 
Fat + Protein (kg)  726 838 865 15.8 
SCS 2.21 2.33 2.63 0.13 
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Table 5.  Estimates of heritability (in bold on the diagonal, with SE in parentheses) from the univariate 
analysis, and genetic correlations (above the diagonal, with SE in parentheses) and phenotypic correlations 
(below the diagonal, with SE in parentheses) from pairwise bivariate analysis for the treatment costs of 5 
health categories1 and total health treatment cost (THC) for first parity 
 MAST REPRO LAME META MISC THC 
MAST 0.13* (0.05) 0.85* (0.20) 0.34 (0.28) 0.52 (0.27) 0.66 (0.34) 0.92* (0.10) 
REPRO 0.00 (0.02) 0.04 (0.03) 0.41 (0.35) 0.73* (0.29) 0.59 (0.40) 0.91* (0.09) 
LAME 0.03 (0.02) −0.01 (0.02) 0.10* (0.04) 0.56* (0.25) 0.21 (0.38) 0.65* (0.18) 
META 0.02 (0.02) 0.14* (0.02) 0.02 (0.02) 0.12* (0.05) 0.40 (0.37) 0.85* (0.10) 
MISC 0.04* (0.02) 0.02 (0.02) −0.05* (0.02) 0.16* (0.02) 0.04 (0.03) 0.72* (0.20) 
THC 0.34* (0.02) 0.66* (0.01) 0.27* (0.02) 0.63* (0.01) 0.39* (0.02) 0.27* (0.07) 
1  MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and 
 MISC = miscellaneous. 
* Estimate was significantly different from zero based on 95% CI. 
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Table 6.  Estimates of heritability (in bold on the diagonal, with SE in parentheses) from 
the univariate analysis, and genetic correlations (above diagonal, with SE in parentheses) 
and phenotypic correlations (below diagonal, with SE in parentheses) from pairwise 
bivariate analysis for the cost of 4 specific health treatments for first parity 
 Metritis 
Retained 
placenta 
Displaced 
abomasum Ketosis 
Metritis 0.02 (0.02) 0.66 (0.48) 0.79* (0.23) ---1 
Retained placenta 0.21* (0.02) 0.12* (0.05) −0.37 (0.27) 0.88* (0.20) 
Displaced abomasum 0.16* (0.02) 0.01 (0.02) 0.12* (0.05) 0.97* (0.15) 
Ketosis ---1 0.06* (0.02) 0.24* (0.02) 0.18* (0.07) 
*  Estimate was significantly different from zero based on 95% CI. 
1  Convergence was not achieved. 
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Table 7. Genetic and phenotypic correlations (SE in parentheses) of 
total health cost (THC) with 305-d production and SCS for first 
parity from pairwise bivariate analysis 
 THC 
Trait Genetic Phenotypic 
Milk 0.44* (0.18) −0.07* (0.02) 
Fat 0.07 (0.21) −0.08* (0.02) 
Protein 0.28 (0.20) −0.10* (0.02) 
Fat + Protein 0.18 (0.21) −0.09* (0.02) 
SCS 0.93* (0.13) 0.14* (0.02) 
* Estimate was significantly different from zero based on 95% CI. 
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Table 8. Genetic and phenotypic correlations (SE in parentheses) of conformation1 with the treatment costs of 5 health 
categories, total health cost (THC), and 4 specific health treatments for first parity from pairwise bivariate analysis 
 Stature  Dairy form  Udder depth 
Trait2 Genetic Phenotypic  Genetic Phenotypic  Genetic Phenotypic 
MAST −0.22 (0.21) 0.04* (0.02)  −0.30 (0.21) 0.01 (0.02)  −0.84* (0.17) −0.11* (0.02) 
REPRO 0.09 (0.33) 0.01 (0.02)  −0.36 (0.34) 0.04* (0.02)  −0.65* (0.27) 0.02 (0.02) 
LAME 0.01 (0.22) 0.04* (0.02)  −0.12 (0.22) −0.01 (0.02)  −0.37 (0.24) 0.00 (0.02) 
META 0.21 (0.22) 0.04* (0.02)  −0.21 (0.24) 0.02 (0.02)  −0.35 (0.22) −0.02 (0.02) 
MISC −0.40 (0.31) −0.01 (0.02)  −0.07 (0.30) 0.04* (0.02)  −0.35 (0.31) −0.04* (0.02) 
THC −0.05 (0.17) 0.04 (0.03)  −0.23 (0.18) 0.05* (0.02)  −0.60* (0.16) −0.04* (0.02) 
Metritis 0.33 (0.48) 0.01 (0.02)  −0.21 (0.45) 0.02 (0.02)  −0.74 (0.39) 0.01 (0.02) 
Retained placenta 0.19 (0.22) 0.04* (0.02)  −0.27 (0.22) 0.02 (0.02)  −0.25 (0.23) 0.05* (0.02) 
Displaced abomasum 0.31 (0.21) 0.04* (0.02)  −0.07 (0.23) 0.01 (0.02)  −0.27 (0.23) −0.01 (0.02) 
Ketosis 0.21 (0.20) 0.03 (0.02)  −0.07 (0.21) 0.04* (0.02)  −0.43* (0.20) −0.02 (0.02) 
1  Higher scores were assigned to taller cows for stature, more angular cows for dairy form, and more shallow cows for udder  
 depth. 
2  MAST = mastitis, REPRO = reproduction, LAME = lameness, META = metabolic, and MISC = miscellaneous. 
* Estimate was significantly different from zero based on 95% CI. 
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Table 9.  Estimates of heritability (SE in parentheses) for total health treatment 
cost (THC) and 305-d production and SCS for parities 1 to 3 from multivariate 
analysis across parities 
 Parity 
Trait 1 2 3 
THC 0.25* (0.07) 0.16* (0.06) 0.17 (0.11) 
Milk  0.23* (0.06) 0.20* (0.06) 0.19* (0.09) 
Fat 0.20* (0.06) 0.21* (0.07) 0.14 (0.08) 
Protein 0.20* (0.06) 0.11* (0.05) 0.12 (0.08) 
Fat + protein 0.18* (0.06) 0.16* (0.06) 0.13 (0.08) 
SCS 0.18* (0.06) 0.19* (0.07) 0.10 (0.09) 
* Estimate was significantly different from zero based on 95% CI. 
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Figure 1.  The EBV for total health cost (THC) of 53 sires with at least 10 daughters 
versus the mean THC of the corresponding daughters for first parity. 
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